[
  {
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Amgen Inc",
      "Mar"
    ],
    "date": [
      "2002",
      "2003"
    ],
    "title": [
      "filing with the Securities and Exchange Commission",
      "Amgen’s profits were calculated by subtracting the $2.99-billion in-process research-and-development write-off for its acquisition of"
    ],
    "type": "article-journal",
    "volume": [
      "10-K",
      "10"
    ]
  },
  {
    "container-title": [
      "Interview with Mark Brand, Sept"
    ],
    "date": [
      "2001"
    ],
    "title": [
      "Immunex Inc. from its 2002 aftertax net operating loss of $1.39 billion. 2"
    ],
    "type": "article-journal",
    "volume": [
      "10"
    ]
  },
  {
    "author": [
      {
        "family": "release",
        "given": "Amgen",
        "particle": "press"
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Sept"
    ],
    "date": [
      "2001"
    ],
    "title": [
      "FDA Approves Amgen’s Aranesp for Anemia Associated with Chronic Renal Failure"
    ],
    "type": "article-journal",
    "url": [
      "http://www.amgen.com/"
    ],
    "volume": [
      "18"
    ]
  },
  {
    "citation-number": [
      "news/news01/pressrelease010918.html"
    ],
    "note": [
      "accessed Oct. 15, 2003)."
    ],
    "type": null
  },
  {
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Data Profile"
    ],
    "date": [
      "2002-09"
    ],
    "issue": [
      "5"
    ],
    "title": [
      "Georgetown University Center on an Aging Society, “Prescription Drugs, a Vital Component of Health Care"
    ],
    "type": "article-journal",
    "volume": []
  },
  {
    "author": [
      {
        "family": "Foundation",
        "given": "Kaiser Family"
      }
    ],
    "container-title": [
      "Oct",
      "ABC-World News Tonight"
    ],
    "date": [
      "2002",
      "2002-05-29"
    ],
    "title": [
      "The Medicare Program, Medicare and Prescription Drugs",
      "Dozens of news accounts featured the impact on the elderly of rising drug costs; see, for instance, Peter Jennings, “Bitter Medicine"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "5."
    ],
    "note": [
      "See",
      "accessed Oct. 10, 2003)."
    ],
    "title": [
      "The latest data from the Center for Responsive Politics Web site"
    ],
    "type": null,
    "url": [
      "http://www.opensecrets.org"
    ]
  },
  {
    "author": [
      {
        "family": "Alan",
        "given": "F."
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Mar"
    ],
    "date": [
      "2000"
    ],
    "title": [
      "Holmer, prepared testimony, Senate Finance Committee"
    ],
    "type": "article-journal",
    "volume": [
      "22"
    ]
  },
  {
    "author": [
      {
        "family": "Gambardella",
        "given": "Alfonso"
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Pharmaceutical Industry During the 1980s"
    ],
    "pages": [
      "14"
    ],
    "title": [
      "Science and Innovation: The U.S"
    ],
    "type": "chapter"
  },
  {
    "citation-number": [
      "8."
    ],
    "date": [
      "2002"
    ],
    "genre": [
      "Merck Annual Report, chairman’s message,"
    ],
    "type": "report",
    "url": [
      "http://www.merck.com/"
    ]
  },
  {
    "citation-number": [
      "ﬁnance/annualreport/ar2002/chairmans_message.html"
    ],
    "note": [
      "accessed Oct. 15, 2003)."
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Drews",
        "given": "Jürgen"
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Biotechnology, and the Future of Drug Research"
    ],
    "pages": [
      "20"
    ],
    "title": [
      "In Quest of Tomorrow’s Medicines: An Eminent Scientist Talks about the Pharmaceutical Industry"
    ],
    "type": "chapter"
  },
  {
    "citation-number": [
      "1."
    ],
    "date": [
      "1999"
    ],
    "title": [
      "This and subsequent comments are from various interviews with Eugene Goldwasser conducted between"
    ],
    "type": null
  },
  {
    "citation-number": [
      "2."
    ],
    "note": [
      "McGraw Hill, 2001), edited by Gilman’s grandson, is still in print and has been translated into nine languages."
    ],
    "title": [
      "The updated version of Goodman and Gilman’s The Pharmacological Basis of Therapeutics"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Fanu",
        "given": "James Le"
      }
    ],
    "citation-number": [
      "3."
    ],
    "note": [
      "See also chapter 7."
    ],
    "pages": [
      "112–13"
    ],
    "title": [
      "The Rise and Fall of Modern Medicine"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Miyake",
        "given": "T."
      },
      {
        "family": "Kung",
        "given": "C.K."
      },
      {
        "family": "Goldwasser",
        "given": "E."
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Journal of Biological Chemistry"
    ],
    "date": [
      "1977-08-10"
    ],
    "pages": [
      "5558–64"
    ],
    "title": [
      "Purification of Human Erythropoietin"
    ],
    "type": "article-journal",
    "volume": [
      "252(15"
    ]
  },
  {
    "author": [
      {
        "family": "Goldwasser",
        "given": "Eugene"
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Perspective in Biology and Medicine"
    ],
    "date": [
      "1996"
    ],
    "note": [
      "quote on"
    ],
    "pages": [
      "18–32",
      "25"
    ],
    "title": [
      "Erythropoietin: A Somewhat Personal History"
    ],
    "type": "article-journal",
    "volume": [
      "40"
    ]
  },
  {
    "citation-number": [
      "6."
    ],
    "location": [
      "Martin Kenney, Biotechnology"
    ],
    "pages": [
      "23"
    ],
    "publisher": [
      "The University-Industrial Complex"
    ],
    "type": "book"
  },
  {
    "citation-number": [
      "7."
    ],
    "date": [
      "1997-05-08"
    ],
    "publisher": [
      "University of California at Berkeley"
    ],
    "title": [
      "Oral history with Niels Reimers, Bancroft Library"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Panem",
        "given": "Sandra"
      }
    ],
    "citation-number": [
      "8."
    ],
    "pages": [
      "72"
    ],
    "title": [
      "The Interferon Crusade"
    ],
    "type": null
  },
  {
    "citation-number": [
      "9."
    ],
    "date": [
      "2000-05-27"
    ],
    "title": [
      "Interview with George Rathmann"
    ],
    "type": null
  },
  {
    "citation-number": [
      "10."
    ],
    "date": [
      "2000-07-25"
    ],
    "title": [
      "Interview with Fu-Kuen Lin"
    ],
    "type": null
  },
  {
    "citation-number": [
      "11."
    ],
    "container-title": [
      "v. Chugai Pharmaceutical Co., Ltd., and Genetics Institute, Inc., U.S. District Court for the District of Massachusetts"
    ],
    "date": [
      "1989-12-11"
    ],
    "title": [
      "A detailed chronology of both Amgen’s and Genetics Institute’s search for the Epo gene is contained in Amgen Inc"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "given": "Ibid"
      }
    ],
    "citation-number": [
      "12."
    ],
    "pages": [
      "12"
    ],
    "type": null
  },
  {
    "citation-number": [
      "13."
    ],
    "container-title": [
      "Sept"
    ],
    "date": [
      "2001"
    ],
    "title": [
      "Interview with Daniel Vapnek"
    ],
    "type": "article-journal",
    "volume": [
      "26"
    ]
  },
  {
    "citation-number": [
      "14."
    ],
    "container-title": [
      "Biotechnology News"
    ],
    "date": [
      "1995-07-21"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Victor Cohn",
        "given": "Lin",
        "particle": "interview."
      }
    ],
    "citation-number": [
      "15."
    ],
    "container-title": [
      "Washington Post, Apr"
    ],
    "date": [
      "1980"
    ],
    "title": [
      "Revolutionary Gene Transfer Is Achieved"
    ],
    "type": "article-journal",
    "volume": [
      "11"
    ]
  },
  {
    "citation-number": [
      "16."
    ],
    "container-title": [
      "Chugai and Genetics Institute"
    ],
    "pages": [
      "12"
    ],
    "title": [
      "Amgen v"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Carlson",
        "given": "William Rob"
      },
      {
        "family": "Jacobs",
        "given": "See K."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "17."
    ],
    "container-title": [
      "Nature, Feb"
    ],
    "date": [
      "1988",
      "1985"
    ],
    "genre": [
      "(Ph.D. diss.,"
    ],
    "pages": [
      "18"
    ],
    "publisher": [
      "Princeton University"
    ],
    "title": [
      "Erythropoietin: The Development of a Pharmaceutical Product",
      "Isolation and Characterization of Genomic and CDNA Clones of Human Erythropoietin"
    ],
    "type": "article-journal",
    "volume": [
      "28"
    ]
  },
  {
    "citation-number": [
      "18."
    ],
    "title": [
      "The Amgen – Genetics Institute case would drag out until mid-1995, when the Supreme Court finally decided not to hear an appeal of the Appeals Court decision in favor of Amgen"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Eschbach",
        "given": "J.W."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "19."
    ],
    "container-title": [
      "New England Journal of Medicine"
    ],
    "date": [
      "1987-01-08"
    ],
    "title": [
      "Correction of the Anemia of End-stage Renal Disease with Recombinant Human Erythropoietin. Results of a Combined Phase I and II Clinical Trial"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Johannes",
        "given": "Laura"
      }
    ],
    "citation-number": [
      "20."
    ],
    "container-title": [
      "Wall Street Journal"
    ],
    "date": [
      "2001-06-11"
    ],
    "title": [
      "Unsolved Mystery: Cystic Fibrosis Gave Up Its Gene Twelve Years Ago: Where’s the Cure?"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Fanu",
        "given": "Le"
      }
    ],
    "citation-number": [
      "21."
    ],
    "pages": [
      "259"
    ],
    "title": [
      "The Rise and Fall of Modern Medicine"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Revkin",
        "given": "Andrew C."
      }
    ],
    "citation-number": [
      "22."
    ],
    "container-title": [
      "New York Times"
    ],
    "date": [
      "1987-01-22"
    ],
    "title": [
      "Firm May Have Found Key to Treating Anemia; Rare Hormone Holds Promise for Kidney Ills"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Ways",
        "given": "House"
      },
      {
        "family": "Committee",
        "given": "Means"
      }
    ],
    "citation-number": [
      "23."
    ],
    "container-title": [
      "Oct"
    ],
    "date": [
      "1991"
    ],
    "title": [
      "Hearing on Health Care Costs, 102nd Cong., 1st sess"
    ],
    "type": "article-journal",
    "volume": [
      "10"
    ]
  },
  {
    "author": [
      {
        "family": "Howard Grossman",
        "given": "Interview",
        "particle": "with"
      }
    ],
    "citation-number": [
      "24."
    ],
    "container-title": [
      "Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) meeting in Chicago"
    ],
    "date": [
      "2001-12-18"
    ],
    "title": [
      "I interviewed Grossman during his presentation at the forty-first Annual"
    ],
    "type": "paper-conference"
  },
  {
    "author": [
      {
        "family": "Daniel Vapnek",
        "given": "Interview",
        "particle": "with"
      },
      {
        "given": "Sept"
      }
    ],
    "citation-number": [
      "25."
    ],
    "container-title": [
      "NOTES TO PAGES"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "– 45 263"
    ],
    "title": [
      "By the end of the 1990s"
    ],
    "type": "chapter",
    "volume": [
      "34"
    ]
  },
  {
    "author": [
      {
        "family": "Stavro",
        "given": "Barry"
      }
    ],
    "container-title": [
      "Los Angeles Times, Sept",
      "Biotechnology News"
    ],
    "date": [
      "1995",
      "1995-08-18"
    ],
    "pages": [
      "27"
    ],
    "title": [
      "Amgen was repurchasing nearly $1 billion a year of its own stock, according to its 1999 10-K filing with the Securities and Exchange Commission",
      "Amgen Faces Weighty Task with Fat-Reduction Drug"
    ],
    "type": "article-journal",
    "volume": [
      "26",
      "5"
    ]
  },
  {
    "author": [
      {
        "family": "Kolata",
        "given": "Gina"
      }
    ],
    "citation-number": [
      "28."
    ],
    "container-title": [
      "New York Times"
    ],
    "date": [
      "1999-10-27"
    ],
    "title": [
      "Hormone That Slimmed Fat Mice Disappoints as Panacea in People"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Klippel",
        "given": "See John H."
      },
      {
        "family": "J. M. Bathon",
        "given": "See",
        "particle": "also"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "29."
    ],
    "container-title": [
      "New England Journal of Medicine"
    ],
    "date": [
      "2000-11-30"
    ],
    "title": [
      "Biologic Therapy for Rheumatoid Arthritis",
      "A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Schuster",
        "given": "Larry"
      },
      {
        "family": "Pollack",
        "given": "Andrew"
      },
      {
        "given": "Klippel"
      }
    ],
    "container-title": [
      "New England Journal of Medicine",
      "Biotechnology Newswatch",
      "New York Times",
      "Nov"
    ],
    "date": [
      "2000-11-30",
      "2001-12-03",
      "2001-12-17",
      "2000"
    ],
    "note": [
      "Interview with Doyt Conn, May 23, 2002."
    ],
    "pages": [
      "30",
      "31"
    ],
    "title": [
      "Arthritis",
      "Prescribing Pain Fighters Proving Big Headache for Joint Docs",
      "Amgen Buys Biotech Rival Immunex for $16 Billion",
      "Biologic Therapy"
    ],
    "type": "article-journal",
    "volume": [
      "30"
    ]
  },
  {
    "citation-number": [
      "32."
    ],
    "container-title": [
      "Chicago Tribune"
    ],
    "date": [
      "1999-05-24"
    ],
    "title": [
      "Garabed Eknoyan, professor of medicine at Baylor University and cochair of the National Kidney Foundation’s Dialysis Outcomes Quality Initiative (DOQI), lists himself as a paid consultant to Amgen at continuing medical education seminars where he teaches; Allen Nissenson, a professor of medicine at UCLA and a member of DOQI, is on the company’s advisory board. A full account of this issue can be found in Merrill Goozner, “The Making of a Star Drug"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Allen Nissenson",
        "given": "Interview",
        "particle": "with"
      },
      {
        "given": "Feb"
      }
    ],
    "citation-number": [
      "33."
    ],
    "date": [
      "1999"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Rundle",
        "given": "Rhonda L."
      },
      {
        "family": "Johannes",
        "given": "Laura"
      }
    ],
    "citation-number": [
      "34."
    ],
    "container-title": [
      "Wall Street Journal"
    ],
    "date": [
      "2001-01-22"
    ],
    "title": [
      "Ruling Against Transkaryotic Therapies Saves Amgen’s Monopoly on Anemia Drug"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Bush",
        "given": "Vannevar"
      }
    ],
    "citation-number": [
      "1."
    ],
    "date": [
      "1945"
    ],
    "location": [
      "Washington, D.C"
    ],
    "publisher": [
      "U.S. Government Printing Office"
    ],
    "title": [
      "Science, the Endless Frontier: A Report to the President"
    ],
    "type": "book"
  },
  {
    "citation-number": [
      "2."
    ],
    "note": [
      "New Yorker, June 4, 2001. For more on the war on cancer, see chapter 7."
    ],
    "title": [
      "A good example of that reasoning can be found in Jerome Groopman, “The Thirty Years’ War: Have We Been Fighting Cancer the Wrong Way?"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Greenberg",
        "given": "Daniel S."
      },
      {
        "given": "Science"
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Political Triumph and Ethical Erosion"
    ],
    "pages": [
      "419"
    ],
    "title": [
      "Money, and Politics"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "John Barranger",
        "given": "Interview",
        "particle": "with"
      },
      {
        "given": "Mar"
      }
    ],
    "citation-number": [
      "4."
    ],
    "date": [
      "2002"
    ],
    "type": null
  },
  {
    "citation-number": [
      "5."
    ],
    "date": [
      "2001"
    ],
    "title": [
      "This and subsequent comments from Roscoe Brady were gleaned from numerous interviews conducted during 2000"
    ],
    "type": null
  },
  {
    "citation-number": [
      "6."
    ],
    "date": [
      "1992"
    ],
    "location": [
      "Washington, D.C"
    ],
    "title": [
      "Office of Technology Assessment, Federal and Private Roles in the Development and Provision of Alglucerase Therapy for Gaucher Disease"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "interviews",
        "given": "Brady"
      }
    ],
    "citation-number": [
      "7."
    ],
    "type": null
  },
  {
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Federal and Private Roles"
    ],
    "pages": [
      "1–2"
    ],
    "title": [
      "See Office of Technology Assessment"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Ernest Beutler",
        "given": "Interview",
        "particle": "with"
      },
      {
        "given": "Mar"
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "proponent of the idea that low doses of 264 NOTES TO PAGES 45"
    ],
    "date": [
      "2002"
    ],
    "note": [
      "enzyme are just as effective as Genzyme’s recommended higher doses in treating Gaucher disease (see the discussion of price below)."
    ],
    "pages": [
      "– 57"
    ],
    "title": [
      "Beutler is a thorn in Genzyme’s side since he is the chief U.S"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "John Barranger",
        "given": "Interview",
        "particle": "with"
      },
      {
        "given": "Mar"
      }
    ],
    "citation-number": [
      "10."
    ],
    "date": [
      "2002"
    ],
    "note": [
      "see chapter 1)."
    ],
    "title": [
      "Of course, Amgen, where Fu-Kuen Lin was finishing his work at about the same time, did patent their gene’s use for the expression of erythropoietin"
    ],
    "type": null
  },
  {
    "citation-number": [
      "11."
    ],
    "date": [
      "2002-06-13"
    ],
    "title": [
      "Interview with Robin Ely Berman"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "interviews",
        "given": "Brady"
      }
    ],
    "citation-number": [
      "12."
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Asbury",
        "given": "Carolyn H."
      }
    ],
    "citation-number": [
      "13."
    ],
    "container-title": [
      "Orphan Drugs, Medical versus Market Value"
    ],
    "pages": [
      "111"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "14."
    ],
    "container-title": [
      "Apr"
    ],
    "date": [
      "2002"
    ],
    "title": [
      "Interview with Marlene Haffner"
    ],
    "type": "article-journal",
    "volume": [
      "12"
    ]
  },
  {
    "citation-number": [
      "15."
    ],
    "pages": [
      "2"
    ],
    "title": [
      "Office of Technology Assessment, Federal and Private Roles"
    ],
    "type": null
  },
  {
    "citation-number": [
      "16."
    ],
    "date": [
      "2001-10-18"
    ],
    "title": [
      "Interview with Abby Meyers"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Record",
        "given": "Congressional"
      }
    ],
    "citation-number": [
      "17."
    ],
    "container-title": [
      "Apr"
    ],
    "date": [
      "1993"
    ],
    "issue": [
      "44"
    ],
    "pages": [
      "1851"
    ],
    "type": "article-journal",
    "volume": [
      "1",
      "138"
    ]
  },
  {
    "author": [
      {
        "family": "Kassebaum",
        "given": "Nancy"
      },
      {
        "family": "Metzenbaum",
        "given": "Howard"
      }
    ],
    "citation-number": [
      "18."
    ],
    "date": [
      "1992-06-23"
    ],
    "genre": [
      "Washington Post,"
    ],
    "title": [
      "Wonder Drugs and Scare Talk"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Termeer",
        "given": "Henri A."
      }
    ],
    "citation-number": [
      "19."
    ],
    "container-title": [
      "Wall Street Journal"
    ],
    "date": [
      "1993-11-16"
    ],
    "title": [
      "Pricing: The Cost of Miracles"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "given": "Patent"
      },
      {
        "family": "Office",
        "given": "Trademark"
      }
    ],
    "citation-number": [
      "20."
    ],
    "date": [
      "1993-08-17"
    ],
    "issue": [
      "5,236,838"
    ],
    "pages": [
      "13"
    ],
    "title": [
      "Office of Technology Assessment, “Federal and Private Roles"
    ],
    "type": null,
    "volume": []
  },
  {
    "citation-number": [
      "21."
    ],
    "date": [
      "2002-06-06"
    ],
    "title": [
      "Interview with Roscoe Brady"
    ],
    "type": null
  },
  {
    "citation-number": [
      "22."
    ],
    "note": [
      "accessed Oct. 15, 2003)."
    ],
    "title": [
      "A list of orphan drugs, both those still under investigation and those approved, is available on the Web site of the Food and Drug Administration’s Office of Orphan Products Development"
    ],
    "type": null,
    "url": [
      "http://www.fda.gov/orphan/designat/"
    ]
  },
  {
    "author": [
      {
        "family": "interview",
        "given": "Meyers"
      }
    ],
    "citation-number": [
      "23."
    ],
    "type": null
  },
  {
    "citation-number": [
      "24."
    ],
    "container-title": [
      "Mar"
    ],
    "date": [
      "2002"
    ],
    "title": [
      "Interview with David Calhoun"
    ],
    "type": "article-journal",
    "volume": [
      "16"
    ]
  },
  {
    "author": [
      {
        "family": "Calhoun",
        "given": "D.H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "25."
    ],
    "container-title": [
      "Proceedings of the National Academy of Science"
    ],
    "date": [
      "1985-11"
    ],
    "pages": [
      "7364–68"
    ],
    "title": [
      "Fabry Disease: Isolation of a CDNA Clone Encoding Human Alpha-Galactosidase A"
    ],
    "type": "paper-conference"
  },
  {
    "citation-number": [
      "26."
    ],
    "container-title": [
      "Mar"
    ],
    "date": [
      "2002"
    ],
    "title": [
      "Interview with Yiannis Ioannou"
    ],
    "type": "article-journal",
    "volume": [
      "25"
    ]
  },
  {
    "author": [
      {
        "given": "Patent"
      },
      {
        "family": "Office",
        "given": "Trademark"
      }
    ],
    "citation-number": [
      "27."
    ],
    "date": [
      "1994-10-18"
    ],
    "issue": [
      "5,356,804"
    ],
    "type": null,
    "volume": []
  },
  {
    "author": [
      {
        "given": "F.D.A."
      }
    ],
    "citation-number": [
      "28."
    ],
    "title": [
      "Office of Orphan Products Development, Web site"
    ],
    "type": null,
    "url": [
      "http://www.fda"
    ]
  },
  {
    "author": [
      {
        "family": "list.html",
        "particle": "gov/orphan/designat/"
      }
    ],
    "date": [
      "2003-10-15"
    ],
    "type": null
  },
  {
    "citation-number": [
      "29."
    ],
    "container-title": [
      "Feb"
    ],
    "date": [
      "2002"
    ],
    "title": [
      "Interview with Jack Johnson, president of the Fabry Information and Support Group"
    ],
    "type": "article-journal",
    "volume": [
      "27"
    ]
  },
  {
    "citation-number": [
      "30."
    ],
    "date": [
      "2002-06-04"
    ],
    "title": [
      "Interview with Frank Landsberger"
    ],
    "type": null
  },
  {
    "citation-number": [
      "31."
    ],
    "date": [
      "2002-06-04"
    ],
    "title": [
      "E-mail communication from Lowell Weiner, assistant vice president for public relations at Wyeth, which now owns Genetics Institute"
    ],
    "type": null
  },
  {
    "citation-number": [
      "32."
    ],
    "container-title": [
      "Apr"
    ],
    "date": [
      "2002"
    ],
    "title": [
      "Interview with Richard Selden"
    ],
    "type": "article-journal",
    "volume": [
      "4"
    ]
  },
  {
    "citation-number": [
      "33."
    ],
    "edition": [
      "34. Selden interview. 35. Ibid"
    ],
    "title": [
      "Ioannou interview"
    ],
    "type": null
  },
  {
    "citation-number": [
      "36."
    ],
    "container-title": [
      "Transkaryotic Therapies Inc. (TKT), initial registration statement with the Securities and Exchange Commission"
    ],
    "date": [
      "1996-08-27"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Corp",
        "given": "Genzyme"
      }
    ],
    "citation-number": [
      "37."
    ],
    "title": [
      "10-K (1993 – 2001) filings with the Securities and Exchange Commission"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Schiffmann",
        "given": "Raphael"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "38."
    ],
    "container-title": [
      "Journal of the American Medical Association"
    ],
    "date": [
      "2001-06-06"
    ],
    "publisher": [
      "Christine M"
    ],
    "title": [
      "Enzyme Replacement Therapy in Fabry Dis-NOTES TO PAGES 57 – 70 265 ease"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "given": "Eng"
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "New England Journal of Medicine"
    ],
    "date": [
      "2001-07-05"
    ],
    "title": [
      "Safety and Efficacy of Recombinant Human a-Galactosidase: A Replacement Therapy in Fabry’s Disease"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "39."
    ],
    "container-title": [
      "Mar"
    ],
    "date": [
      "2002"
    ],
    "title": [
      "Interview with Gregory Pastores"
    ],
    "type": "article-journal",
    "volume": [
      "27"
    ]
  },
  {
    "author": [
      {
        "family": "Corp",
        "given": "Genzyme"
      }
    ],
    "citation-number": [
      "40."
    ],
    "container-title": [
      "Apr"
    ],
    "date": [
      "2001",
      "2002"
    ],
    "pages": [
      "10–"
    ],
    "title": [
      "filing with the Securities and Exchange Commission"
    ],
    "type": "article-journal",
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "Michael Russo",
        "given": "Interview",
        "particle": "with"
      }
    ],
    "citation-number": [
      "41."
    ],
    "date": [
      "2002-06-20"
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Ibid"
      }
    ],
    "citation-number": [
      "42."
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Raphael Schiffmann",
        "given": "Interview",
        "particle": "with"
      },
      {
        "given": "Jan"
      }
    ],
    "citation-number": [
      "43."
    ],
    "date": [
      "2003"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Middleton",
        "given": "Otesa"
      }
    ],
    "citation-number": [
      "44."
    ],
    "container-title": [
      "Dow Jones Newswires, Mar"
    ],
    "date": [
      "2002"
    ],
    "title": [
      "FDA Says Serono’s Rebif Approval a Rare Case"
    ],
    "type": "article-journal",
    "volume": [
      "8"
    ]
  },
  {
    "author": [
      {
        "family": "MACHINE",
        "given": "T.H.E.S.O.U.R.C.E.O.F.T.H.E.N.E.W."
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "New York Times"
    ],
    "date": [
      "2000-06-27"
    ],
    "title": [
      "Reading the Book of Life: White House Remarks on Decoding of Genome"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Preston",
        "given": "Richard"
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "New Yorker"
    ],
    "date": [
      "2000-06-12"
    ],
    "pages": [
      "66"
    ],
    "title": [
      "The Genome Warrior"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Times transcript of President Bill Clinton’s press conference"
    ],
    "date": [
      "2000-06-27"
    ],
    "location": [
      "New York"
    ],
    "type": "paper-conference"
  },
  {
    "author": [
      {
        "family": "Davies",
        "given": "Kevin"
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Cracking the Genome"
    ],
    "pages": [
      "238"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Press conference, Capitol Hilton Hotel"
    ],
    "date": [
      "2000-06-26"
    ],
    "location": [
      "Washington, D.C"
    ],
    "type": "paper-conference"
  },
  {
    "author": [
      {
        "family": "Kiley",
        "given": "Thomas D."
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Science"
    ],
    "date": [
      "1992-08-14"
    ],
    "pages": [
      "915 7"
    ],
    "publisher": [
      "Ibid"
    ],
    "title": [
      "Patents on Random Complementary DNA Fragments?"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "8."
    ],
    "container-title": [
      "sess"
    ],
    "date": [
      "2000-07-13"
    ],
    "title": [
      "Hearing of the House Judiciary Subcommittee on Courts and Intellectual Property, 106th Cong., 2nd"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Press conference"
    ],
    "date": [
      "2000-06-26"
    ],
    "type": "paper-conference"
  },
  {
    "author": [
      {
        "given": "Davies"
      }
    ],
    "citation-number": [
      "10."
    ],
    "pages": [
      "207"
    ],
    "title": [
      "Cracking the Genome"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Jacobs",
        "given": "Paul"
      },
      {
        "family": "Zitner",
        "given": "Aaron"
      }
    ],
    "citation-number": [
      "11."
    ],
    "container-title": [
      "Los Angeles Times"
    ],
    "date": [
      "2000-06-27"
    ],
    "title": [
      "Genome Milestone: Cracking the Code"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "given": "Cook-Deegan"
      }
    ],
    "citation-number": [
      "12."
    ],
    "note": [
      "Cook-Deegan is quoting from F."
    ],
    "pages": [
      "61"
    ],
    "title": [
      "The Gene Wars"
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Sanger"
      },
      {
        "family": "Gosselin",
        "given": "Peter G."
      },
      {
        "family": "Jacobs",
        "given": "Paul"
      }
    ],
    "collection-title": [
      "Ibid. (The Gene Wars"
    ],
    "container-title": [
      "Annual Review of Biochemistry",
      "Los Angeles Times, Feb"
    ],
    "date": [
      "1988",
      "2000"
    ],
    "pages": [
      "1–28 13",
      "64–67 14"
    ],
    "title": [
      "Sequences, Sequences, and Sequences",
      "U.S. Officials Probe Cost of Genetic Decoder"
    ],
    "type": "article-journal",
    "volume": [
      "57",
      "16"
    ]
  },
  {
    "author": [
      {
        "given": "Cook-Deegan"
      }
    ],
    "citation-number": [
      "15."
    ],
    "pages": [
      "66"
    ],
    "title": [
      "The Gene Wars"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Fishlock",
        "given": "David"
      }
    ],
    "citation-number": [
      "16."
    ],
    "container-title": [
      "Financial Times (London), Aug"
    ],
    "date": [
      "1983"
    ],
    "pages": [
      "5"
    ],
    "title": [
      "How Applied Biosystems Produces Biotechnology Tools"
    ],
    "type": "article-journal",
    "volume": [
      "22"
    ]
  },
  {
    "citation-number": [
      "17."
    ],
    "container-title": [
      "Michael Barbaro, “Patent Fight Erupts over Gene Machine,” Washington Post"
    ],
    "date": [
      "July 15"
    ],
    "title": [
      "Huang was never included on the patent, which became a subject of litigation nineteen years later. MJ Research, which wanted to build a competitor machine using the technology, filed a qui tam suit against Applied Biosystems alleging it had overcharged the government for the machines"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "given": "Gosselin"
      },
      {
        "given": "Jacobs"
      }
    ],
    "citation-number": [
      "18."
    ],
    "container-title": [
      "Los Angeles Times, Feb"
    ],
    "date": [
      "2000"
    ],
    "title": [
      "U.S. Officials Probe Cost of Genetic Decoder"
    ],
    "type": "article-journal",
    "volume": [
      "16"
    ]
  },
  {
    "author": [
      {
        "given": "Cook-Deegan"
      }
    ],
    "citation-number": [
      "19."
    ],
    "pages": [
      "88"
    ],
    "title": [
      "The Gene Wars"
    ],
    "type": null
  },
  {
    "citation-number": [
      "20."
    ],
    "date": [
      "2000-08-24"
    ],
    "title": [
      "Interview with Marvin Stodolsky"
    ],
    "type": null
  },
  {
    "citation-number": [
      "21."
    ],
    "container-title": [
      "Oct"
    ],
    "date": [
      "2000"
    ],
    "title": [
      "Interview with Lloyd Smith"
    ],
    "type": "article-journal",
    "volume": [
      "16"
    ]
  },
  {
    "author": [
      {
        "family": "Joseph Jaklevic",
        "given": "Interview",
        "particle": "with"
      },
      {
        "given": "Jan"
      }
    ],
    "citation-number": [
      "22."
    ],
    "date": [
      "2002"
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Ibid"
      }
    ],
    "citation-number": [
      "23."
    ],
    "type": null
  },
  {
    "citation-number": [
      "24."
    ],
    "container-title": [
      "Sept"
    ],
    "date": [
      "2000"
    ],
    "title": [
      "Interview with Richard Mathies"
    ],
    "type": "article-journal",
    "volume": [
      "15"
    ]
  },
  {
    "citation-number": [
      "25."
    ],
    "date": [
      "2000-10-15"
    ],
    "title": [
      "Interview with Jingyue Ju"
    ],
    "type": null
  },
  {
    "citation-number": [
      "26."
    ],
    "container-title": [
      "Oct"
    ],
    "date": [
      "2000"
    ],
    "title": [
      "Interview with Roy Whitfield"
    ],
    "type": "article-journal",
    "volume": [
      "16"
    ]
  },
  {
    "citation-number": [
      "27."
    ],
    "date": [
      "2002-07-09"
    ],
    "title": [
      "Interview with Mike Hunkapillar"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Wade",
        "given": "Nicholas"
      }
    ],
    "citation-number": [
      "28."
    ],
    "container-title": [
      "New York Times"
    ],
    "date": [
      "1998-05-10"
    ],
    "title": [
      "Scientist’s Plan: Map All DNA within Three Years"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "given": "Preston"
      }
    ],
    "citation-number": [
      "29."
    ],
    "pages": [
      "75"
    ],
    "title": [
      "The Genome Warrior"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Davies",
        "given": "Quoted",
        "particle": "in"
      }
    ],
    "citation-number": [
      "30."
    ],
    "container-title": [
      "Cracking the Genome"
    ],
    "pages": [
      "91–92"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "John Doll",
        "given": "Interview",
        "particle": "with"
      }
    ],
    "citation-number": [
      "31."
    ],
    "date": [
      "2002-07-03"
    ],
    "title": [
      "My statistic of 1,300 patents comes from Doll’s remarks"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Tom Bethell",
        "given": "Quoted",
        "particle": "in"
      }
    ],
    "citation-number": [
      "32."
    ],
    "container-title": [
      "American Spectator"
    ],
    "date": [
      "2001-04"
    ],
    "title": [
      "A Map to Nowhere"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Hamilton",
        "given": "David P."
      }
    ],
    "citation-number": [
      "33."
    ],
    "container-title": [
      "Wall Street Journal, Apr"
    ],
    "date": [
      "2001"
    ],
    "title": [
      "Myriad Genetics Unveils a Project to Catalog Every Protein in Humans"
    ],
    "type": "article-journal",
    "volume": [
      "4"
    ]
  },
  {
    "citation-number": [
      "34."
    ],
    "date": [
      "2002-07-08"
    ],
    "publisher": [
      "Rutgers University"
    ],
    "title": [
      "Interview with Helen Berman, director of the Protein Data Bank, department of chemistry"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Eisenberg",
        "given": "Rebecca S."
      }
    ],
    "citation-number": [
      "35."
    ],
    "container-title": [
      "Health Affairs, Sept./Oct"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "127 36"
    ],
    "publisher": [
      "Ibid"
    ],
    "title": [
      "The Shifting Functional Balance of Patents and Drug Regulation"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Brickley",
        "given": "Peg"
      }
    ],
    "citation-number": [
      "37."
    ],
    "container-title": [
      "The Scientist"
    ],
    "date": [
      "2002-07-22"
    ],
    "pages": [
      "19"
    ],
    "title": [
      "New Patent Worries Professors"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Pollack",
        "given": "Andrew"
      }
    ],
    "citation-number": [
      "38."
    ],
    "container-title": [
      "New York Times"
    ],
    "date": [
      "2002-01-23"
    ],
    "title": [
      "Scientist Quits The Company He Led in Quest For Genome"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "39."
    ],
    "container-title": [
      "Patent"
    ],
    "issue": [
      "6,410,294"
    ],
    "title": [
      "Patent and Trademark Office, U.S"
    ],
    "type": "article-journal",
    "volume": []
  },
  {
    "author": [
      {
        "family": "See",
        "given": "for instance"
      },
      {
        "family": "Altman",
        "given": "Lawrence K."
      }
    ],
    "citation-number": [
      "40."
    ],
    "container-title": [
      "New York Times"
    ],
    "date": [
      "2001-05-22"
    ],
    "title": [
      "Cancer Doctors See New Era of Optimism"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "41."
    ],
    "date": [
      "2002-07-22"
    ],
    "title": [
      "Interview with Susan Taylor"
    ],
    "type": null
  },
  {
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Apr"
    ],
    "date": [
      "1993"
    ],
    "note": [
      "archived at"
    ],
    "title": [
      "National Institute for Allergies and Infectious Diseases, update, “Concorde Trial"
    ],
    "type": "article-journal",
    "url": [
      "http://www.aegis.com/news/niaid/1993/"
    ],
    "volume": [
      "1"
    ]
  },
  {
    "citation-number": [
      "CDC93005.html"
    ],
    "note": [
      "accessed Oct. 15, 2003)."
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "James",
        "given": "John"
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "AIDS Treatment News"
    ],
    "date": [
      "1993-06-18"
    ],
    "title": [
      "Berlin Conference Overview"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Jon Cohen",
        "given": "I.",
        "particle": "thank"
      }
    ],
    "citation-number": [
      "3."
    ],
    "title": [
      "author of Shots in the Dark: The Wayward Search for an AIDS Vaccine, for what I consider to be the best of the many metaphors that have been used to describe the disease"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Fried",
        "given": "Stephen"
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "NOTES TO PAGES 91",
      "Washington Post Magazine"
    ],
    "date": [
      "1997-05-18"
    ],
    "pages": [
      "– 107 267"
    ],
    "title": [
      "Cocktail Hour"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "5."
    ],
    "title": [
      "The Vertex saga was documented in Barry Werth, The Billion-Dollar Molecule: One Company’s Quest for the Perfect Drug. The molecule in the title was not the protease inhibitor but the drug aimed at curbing transplant rejections"
    ],
    "type": null
  },
  {
    "citation-number": [
      "6."
    ],
    "date": [
      "2001-06-18"
    ],
    "title": [
      "Interview with Robert Yarchoan"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Kramer",
        "given": "Larry"
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "New York Times Magazine"
    ],
    "date": [
      "1996-07-14"
    ],
    "location": [
      "New York"
    ],
    "title": [
      "A Good News/Bad News AIDS Joke",
      "Andrew Sullivan, “When Plagues End"
    ],
    "type": "article-journal"
  },
  {
    "container-title": [
      "Times Magazine",
      "Time"
    ],
    "date": [
      "1996-11-10",
      "Dec",
      "1997"
    ],
    "pages": [
      "1996– 6,"
    ],
    "title": [
      "Christine Gorman, “The Disease Detective"
    ],
    "type": "article-journal",
    "volume": [
      "30"
    ]
  },
  {
    "author": [
      {
        "family": "Galambos",
        "given": "Louis"
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Washington Post"
    ],
    "date": [
      "1996-12-01"
    ],
    "title": [
      "In the AIDS Fight, Big Is Beautiful: Only the Corporate Giants Can Afford the Cost of Innovation"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "9."
    ],
    "date": [
      "2001-06-21"
    ],
    "title": [
      "Interview with John Erickson"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Pearl",
        "given": "L.H."
      },
      {
        "family": "Taylor",
        "given": "W.R."
      }
    ],
    "citation-number": [
      "10."
    ],
    "container-title": [
      "Nature, Sept"
    ],
    "date": [
      "1987"
    ],
    "pages": [
      "351–54"
    ],
    "title": [
      "A Structural Model for Retroviral Proteases"
    ],
    "type": "article-journal",
    "volume": [
      "24"
    ]
  },
  {
    "citation-number": [
      "11."
    ],
    "date": [
      "2001-07-20"
    ],
    "title": [
      "Interview with John McGowan"
    ],
    "type": null
  },
  {
    "citation-number": [
      "12."
    ],
    "date": [
      "2001-08-23"
    ],
    "title": [
      "Interview with Dale Kempf"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Kevles",
        "given": "Daniel J."
      }
    ],
    "citation-number": [
      "13."
    ],
    "container-title": [
      "Wilson Quarterly"
    ],
    "date": [
      "1995"
    ],
    "pages": [
      "40–48"
    ],
    "title": [
      "The Changed Partnership"
    ],
    "type": "article-journal",
    "volume": [
      "19"
    ]
  },
  {
    "citation-number": [
      "14."
    ],
    "date": [
      "1999-11-19"
    ],
    "location": [
      "London",
      "Biotechnology"
    ],
    "pages": [
      "6 15",
      "13"
    ],
    "publisher": [
      "Kenney"
    ],
    "title": [
      "The Discovery and Development of Penicillin, 1928–1945, Alexander Fleming Laboratory Museum"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Stokes",
        "given": "Donald E."
      },
      {
        "family": "Kevles",
        "particle": "see also"
      }
    ],
    "citation-number": [
      "16."
    ],
    "container-title": [
      "17. Stokes, Pasteur’s Quadrant"
    ],
    "pages": [
      "48",
      "49"
    ],
    "title": [
      "Pasteur’s Quadrant: Basic Science and Technological Innovation",
      "The Changed Partnership"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Kevles",
        "given": "See"
      }
    ],
    "citation-number": [
      "18."
    ],
    "container-title": [
      "19. See Stokes, Pasteur’s Quadrant"
    ],
    "pages": [
      "135"
    ],
    "title": [
      "The Changed Partnership"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "given": "Cohen"
      }
    ],
    "citation-number": [
      "20."
    ],
    "pages": [
      "179"
    ],
    "title": [
      "Shots in the Dark"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "See",
        "given": "for instance"
      },
      {
        "given": "Groopman"
      },
      {
        "family": "also",
        "given": "John C.Bailar"
      },
      {
        "family": "Gornik",
        "given": "Heather L."
      }
    ],
    "citation-number": [
      "21."
    ],
    "container-title": [
      "New England Journal of Medicine"
    ],
    "date": [
      "2001-06-04",
      "1997-05-29"
    ],
    "pages": [
      "52–63",
      "1569–74"
    ],
    "title": [
      "The Thirty Years’ War” in The New Yorker",
      "Cancer Undefeated"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "given": "Cohen"
      }
    ],
    "citation-number": [
      "22."
    ],
    "pages": [
      "6"
    ],
    "title": [
      "Shots in the Dark"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Arno",
        "given": "Peter S."
      },
      {
        "family": "Feiden",
        "given": "Karyn L."
      }
    ],
    "citation-number": [
      "23."
    ],
    "container-title": [
      "Politics and Profit"
    ],
    "pages": [
      "37–46"
    ],
    "title": [
      "Against the Odds: The Story of AIDS Drug Development"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "24."
    ],
    "container-title": [
      "New York Times"
    ],
    "date": [
      "1989-09-28"
    ],
    "title": [
      "Letters to the Editor"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "given": "Arno"
      },
      {
        "given": "Feiden"
      }
    ],
    "citation-number": [
      "25."
    ],
    "pages": [
      "54"
    ],
    "title": [
      "Against the Odds"
    ],
    "type": null
  },
  {
    "citation-number": [
      "26."
    ],
    "container-title": [
      "Jan"
    ],
    "date": [
      "2002"
    ],
    "title": [
      "Interview with Lawrence Corey"
    ],
    "type": "article-journal",
    "volume": [
      "10"
    ]
  },
  {
    "author": [
      {
        "family": "Mahoney",
        "given": "John Thomas"
      },
      {
        "family": "Ryan",
        "given": "Frank"
      }
    ],
    "citation-number": [
      "27."
    ],
    "pages": [
      "192",
      "339"
    ],
    "title": [
      "The Merchants of Life: An Account of the American Pharmaceutical Industry",
      "The Forgotten Plague: How the Battle Against Tuberculosis Was Won and Lost"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Louis Galambos",
        "given": "Scolnick",
        "particle": "quoted in"
      },
      {
        "family": "Sewell",
        "given": "Jane Eliot"
      },
      {
        "family": "AIDS",
        "given": "Confronting"
      }
    ],
    "citation-number": [
      "28."
    ],
    "pages": [
      "8"
    ],
    "title": [
      "The Business History Group and Johns Hopkins University, published by Merck Research Laboratories (undated"
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Galambos"
      },
      {
        "family": "Sewell",
        "given": "Confronting A.I.D.S."
      }
    ],
    "citation-number": [
      "29."
    ],
    "date": [
      "2001-06-15"
    ],
    "pages": [
      "16–17"
    ],
    "publisher": [
      "Interview with Manuel Navia"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Waldholz",
        "given": "Michael"
      }
    ],
    "citation-number": [
      "30."
    ],
    "title": [
      "AIDS—The Race for a Cure—Tracking a Killer"
    ],
    "type": null
  },
  {
    "container-title": [
      "and Navia interview. 268 NOTES TO PAGES 108",
      "Wall Street Journal, Feb"
    ],
    "date": [
      "1989",
      "2001-11-08"
    ],
    "location": [
      "Pennsylvania"
    ],
    "pages": [
      "32",
      "– 125 31"
    ],
    "publisher": [
      "Interview with Emilio Emini, Merck Research Labs, West Point"
    ],
    "title": [
      "See also Werth, Billion-Dollar Molecule"
    ],
    "type": "article-journal",
    "volume": [
      "16"
    ]
  },
  {
    "author": [
      {
        "given": "Werth"
      }
    ],
    "citation-number": [
      "32."
    ],
    "pages": [
      "110"
    ],
    "title": [
      "Billion-Dollar Molecule"
    ],
    "type": null
  },
  {
    "citation-number": [
      "33."
    ],
    "date": [
      "2001-06-28"
    ],
    "title": [
      "Interview with Alexander Wlodawer"
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Galambos"
      },
      {
        "family": "Sewell",
        "given": "Confronting A.I.D.S."
      }
    ],
    "citation-number": [
      "34."
    ],
    "pages": [
      "20"
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Mahoney"
      }
    ],
    "citation-number": [
      "35."
    ],
    "pages": [
      "222–26"
    ],
    "title": [
      "Merchants of Life"
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Panem"
      }
    ],
    "citation-number": [
      "36."
    ],
    "pages": [
      "74"
    ],
    "title": [
      "The Interferon Crusade"
    ],
    "type": null
  },
  {
    "citation-number": [
      "37."
    ],
    "date": [
      "2001-08-14"
    ],
    "title": [
      "Interview with Whaijen Soo"
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Ibid"
      }
    ],
    "citation-number": [
      "38."
    ],
    "date": [
      "2001-07-06"
    ],
    "title": [
      "Interview with Keith Bragman"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Navia",
        "given": "M.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "39."
    ],
    "container-title": [
      "Nature, Feb"
    ],
    "date": [
      "1989"
    ],
    "pages": [
      "615–20"
    ],
    "title": [
      "Three-Dimensional Structure of Aspartyl Protease from Human Immunodeficiency Virus HIV-1"
    ],
    "type": "article-journal",
    "volume": [
      "16"
    ]
  },
  {
    "author": [
      {
        "family": "Noel Roberts",
        "given": "Interview",
        "particle": "with"
      }
    ],
    "citation-number": [
      "40."
    ],
    "date": [
      "2001-08-08"
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Ibid"
      }
    ],
    "citation-number": [
      "41."
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Ibid"
      }
    ],
    "citation-number": [
      "42."
    ],
    "type": null
  },
  {
    "citation-number": [
      "43."
    ],
    "container-title": [
      "Apr"
    ],
    "date": [
      "2001"
    ],
    "title": [
      "Interview with Miklos Salgo"
    ],
    "type": "article-journal",
    "volume": [
      "13"
    ]
  },
  {
    "author": [
      {
        "given": "Ibid"
      }
    ],
    "citation-number": [
      "44."
    ],
    "date": [
      "2001-08-08"
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Drews"
      }
    ],
    "citation-number": [
      "45."
    ],
    "pages": [
      "15–16 46",
      "16"
    ],
    "publisher": [
      "Ibid"
    ],
    "title": [
      "In Quest of Tomorrow’s Medicines"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "interview",
        "given": "Bragman"
      }
    ],
    "citation-number": [
      "47."
    ],
    "type": null
  },
  {
    "citation-number": [
      "48."
    ],
    "container-title": [
      "Drews, In Quest of Tomorrow’s Medicines"
    ],
    "pages": [
      "16"
    ],
    "type": "chapter"
  },
  {
    "citation-number": [
      "5."
    ],
    "container-title": [
      "See also The Discovery and Development of Penicillin"
    ],
    "pages": [
      "129–42",
      "6"
    ],
    "title": [
      "THE DIVORCE 1. Mahoney, Merchants of Life"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Siler",
        "given": "Julia Flynn"
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Business Week"
    ],
    "date": [
      "1989-10-30"
    ],
    "title": [
      "The Slipper Ladder at Abbott Labs"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "3."
    ],
    "note": [
      "See “Ferid Murad—Autobiography” on the Nobel Committee Web site:",
      "accessed Oct. 15, 2003)."
    ],
    "type": null,
    "url": [
      "http://www.nobel.se/medicine/"
    ]
  },
  {
    "citation-number": [
      "4."
    ],
    "date": [
      "2002-01-04"
    ],
    "title": [
      "Interview with Ferid Murad"
    ],
    "type": null
  },
  {
    "citation-number": [
      "5."
    ],
    "date": [
      "2001-08-23"
    ],
    "title": [
      "Interview with Dale Kempf"
    ],
    "type": null
  },
  {
    "citation-number": [
      "6."
    ],
    "date": [
      "2001-07-13"
    ],
    "title": [
      "Interview with John Erickson"
    ],
    "type": null
  },
  {
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Sept"
    ],
    "date": [
      "2001"
    ],
    "title": [
      "Interview with Dan Hoth"
    ],
    "type": "article-journal",
    "volume": [
      "6"
    ]
  },
  {
    "author": [
      {
        "family": "Schwartz",
        "given": "John"
      },
      {
        "family": "McCormick",
        "given": "John"
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Business Week"
    ],
    "date": [
      "1990-05-07"
    ],
    "title": [
      "The CEO Who Won’t Go",
      "Erickson and Murad interviews"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Okie",
        "given": "Susan"
      }
    ],
    "citation-number": [
      "9."
    ],
    "date": [
      "1990-07-27"
    ],
    "genre": [
      "Washington Post,"
    ],
    "title": [
      "Scientists Return to NCI’s Cutting Edge"
    ],
    "type": null
  },
  {
    "citation-number": [
      "10."
    ],
    "container-title": [
      "San Francisco Chronicle, Mar"
    ],
    "date": [
      "1991"
    ],
    "note": [
      "John James, “Clarithromycin: Accessible or Not?” AIDS Treatment"
    ],
    "title": [
      "AIDS Protesters Picket Pharmaceutical Firm"
    ],
    "type": "article-journal",
    "volume": [
      "7"
    ]
  },
  {
    "container-title": [
      "News"
    ],
    "date": [
      "1991-10-18",
      "2001"
    ],
    "editor": [
      {
        "given": "Kempf"
      },
      {
        "family": "Leonard",
        "given": "John"
      }
    ],
    "note": [
      "Hoth interview."
    ],
    "pages": [
      "11"
    ],
    "type": "article-journal",
    "volume": [
      "16"
    ]
  },
  {
    "author": [
      {
        "family": "Bruce Chabner",
        "given": "Letter",
        "particle": "from Andre Pernet to"
      }
    ],
    "citation-number": [
      "12."
    ],
    "container-title": [
      "NOTES TO PAGES"
    ],
    "date": [
      "1991-12-19"
    ],
    "pages": [
      "125 – 138 269"
    ],
    "title": [
      "obtained by Freedom of Information Act (FOIA) request. FOIA officials at the National Institute of Infectious Diseases said a similar correspondence between director Anthony Fauci and Pernet no longer exists"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "given": "Eisenberg"
      }
    ],
    "citation-number": [
      "13."
    ],
    "container-title": [
      "Virginia Law Review"
    ],
    "date": [
      "1996-11"
    ],
    "pages": [
      "1663–1726"
    ],
    "title": [
      "For a comprehensive history of government policy toward intellectual property developed by the public sector, see Rebecca S",
      "Public Research and Private Development: Patents and Technology Transfer in Government-Sponsored Research"
    ],
    "type": "article-journal",
    "volume": [
      "82"
    ]
  },
  {
    "author": [
      {
        "family": "Peter S. Arno",
        "particle": "see"
      },
      {
        "family": "Davis",
        "given": "Michael H."
      }
    ],
    "citation-number": [
      "14."
    ],
    "container-title": [
      "Tulane Law Review"
    ],
    "date": [
      "2001"
    ],
    "issue": [
      "3"
    ],
    "note": [
      "See also Baruch Brody, “Public Goods and Fair Prices: Balancing Technological Innovation with"
    ],
    "pages": [
      "631–93"
    ],
    "title": [
      "For a complete discussion of the Bayh-Dole Act and its implications",
      "Why Don’t We Enforce Existing Drug Price Controls? The Unrecognized and Unenforced Reasonable Pricing Requirements Imposed upon Patents Deriving in Whole or in Part from Federally Funded Research"
    ],
    "type": "article-journal",
    "volume": [
      "75"
    ]
  },
  {
    "author": [
      {
        "family": "Kenney",
        "given": "Biotechnology"
      }
    ],
    "container-title": [
      "The Hastings Center Report"
    ],
    "date": [
      "Mar./Apr. 1996",
      "16",
      "1999-06"
    ],
    "pages": [
      "5–11 15",
      "100"
    ],
    "title": [
      "Social Well-being",
      "Government Accounting Office, “Technology Transfer: Number and Characteristics of Inventions Licensed by Six Federal Agencies"
    ],
    "type": "article-journal",
    "volume": [
      "26"
    ]
  },
  {
    "citation-number": [
      "17."
    ],
    "date": [
      "1992-01-07"
    ],
    "title": [
      "Letter from Bruce Chabner to Andre Pernet"
    ],
    "type": null
  },
  {
    "citation-number": [
      "18."
    ],
    "date": [
      "2001-07-01"
    ],
    "title": [
      "Interview with John Leonard"
    ],
    "type": null
  },
  {
    "citation-number": [
      "19."
    ],
    "date": [
      "1992-05-13"
    ],
    "title": [
      "Letter from Bruce Chabner to John Leonard"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Bruce Chabner",
        "given": "Letter",
        "particle": "from John Leonard to"
      }
    ],
    "citation-number": [
      "20."
    ],
    "date": [
      "1992-06-02"
    ],
    "note": [
      "Also Hoth, Chabner, and Leonard interviews. 21. Hoth interview."
    ],
    "title": [
      "the company nomenclature for the drug, A-77003, was redacted from the National Cancer Institute (NCI) response to my FOIA request"
    ],
    "type": "interview"
  },
  {
    "author": [
      {
        "family": "Mitsuya",
        "given": "Hiroaki"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "22."
    ],
    "container-title": [
      "Journal of the Federation of American Societies for Experimental Biology"
    ],
    "date": [
      "1991-07"
    ],
    "pages": [
      "2369–81"
    ],
    "title": [
      "Targeted Therapy of Human Immunodeficiency Virus-Related Disease"
    ],
    "type": "article-journal",
    "volume": [
      "10"
    ]
  },
  {
    "citation-number": [
      "23."
    ],
    "container-title": [
      "Interview with Emilio Emini"
    ],
    "date": [
      "2001-11-08"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "24."
    ],
    "container-title": [
      "AIDS Treatment News"
    ],
    "date": [
      "1991-11-22"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "interview",
        "given": "Emini"
      }
    ],
    "citation-number": [
      "25."
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "See",
        "given": "for instance"
      },
      {
        "family": "Chase",
        "given": "Marilyn"
      }
    ],
    "citation-number": [
      "26."
    ],
    "container-title": [
      "Wall Street Journal"
    ],
    "date": [
      "1991-11-26"
    ],
    "title": [
      "Merck Setback Shows Problems with AIDS Drugs"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "interview",
        "given": "Erickson"
      },
      {
        "given": "Mar"
      }
    ],
    "citation-number": [
      "27."
    ],
    "date": [
      "2002"
    ],
    "type": null
  },
  {
    "citation-number": [
      "28."
    ],
    "pages": [
      "35"
    ],
    "title": [
      "Scolnick quoted in Galambos and Sewell, Confronting AIDS"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "interview",
        "given": "Emini"
      }
    ],
    "citation-number": [
      "29."
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Chow",
        "given": "Yung-Kang"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "30."
    ],
    "container-title": [
      "Nature, Feb"
    ],
    "date": [
      "1993"
    ],
    "pages": [
      "650–54"
    ],
    "title": [
      "Use of Evolutionary Limitations of HIV-1 Multidrug Resistance to Optimize Therapy"
    ],
    "type": "article-journal",
    "volume": [
      "18"
    ]
  },
  {
    "author": [
      {
        "family": "Aboulker",
        "given": "Jean-Pierre"
      },
      {
        "family": "Swart",
        "given": "Ann Marie"
      }
    ],
    "citation-number": [
      "31."
    ],
    "container-title": [
      "Lancet, Apr"
    ],
    "date": [
      "1993"
    ],
    "pages": [
      "889–90"
    ],
    "title": [
      "Preliminary Analysis of the Concorde Trial” (letters to the editor"
    ],
    "type": "article-journal",
    "volume": [
      "13"
    ]
  },
  {
    "author": [
      {
        "family": "Epstein",
        "given": "Steven"
      }
    ],
    "citation-number": [
      "32."
    ],
    "pages": [
      "308"
    ],
    "title": [
      "Impure Science: AIDS, Activism, and the Politics of Knowledge"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Altman",
        "given": "Lawrence K."
      }
    ],
    "citation-number": [
      "33."
    ],
    "container-title": [
      "New York Times"
    ],
    "date": [
      "1993-07-27"
    ],
    "title": [
      "Faith in Multiple-Drug AIDS Trial Shaken by Report of Error in Lab"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "given": "Ibid"
      }
    ],
    "citation-number": [
      "34."
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "B.R.E.A.K.T.H.R.O.U.G.H.!"
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "NOTES TO PAGES",
      "Patent"
    ],
    "issue": [
      "5,343,866"
    ],
    "note": [
      "Interview with David Ho, Sept. 20, 2001."
    ],
    "pages": [
      "270",
      "138 – 153 2"
    ],
    "title": [
      "1. These dates comes from NIH Grant Number 5U01A1027220-05 and U.S"
    ],
    "type": "article-journal",
    "volume": []
  },
  {
    "author": [
      {
        "family": "Ho",
        "given": "D.D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "letter to New England Journal of Medicine, Mar"
    ],
    "date": [
      "1985"
    ],
    "note": [
      "Ho interview."
    ],
    "pages": [
      "649–50 4"
    ],
    "title": [
      "Antibody to Lymphadenopathy-Associated Virus in AIDS"
    ],
    "type": "article-journal",
    "volume": [
      "7"
    ]
  },
  {
    "author": [
      {
        "family": "Alan Perelson",
        "given": "Interview",
        "particle": "with"
      },
      {
        "given": "Feb"
      }
    ],
    "citation-number": [
      "5."
    ],
    "date": [
      "2002"
    ],
    "type": null
  },
  {
    "citation-number": [
      "6."
    ],
    "note": [
      "Ho interview."
    ],
    "type": "interview"
  },
  {
    "author": [
      {
        "family": "James",
        "given": "John S."
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "AIDS Treatment News"
    ],
    "date": [
      "1990-11-23"
    ],
    "title": [
      "DDC/AZT Combination: Promising Early Results"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Impure Science"
    ],
    "pages": [
      "265–94"
    ],
    "title": [
      "A complete discussion of the AIDS surrogate marker issue is contained in Epstein"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Harrington",
        "given": "Mark"
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "June"
    ],
    "date": [
      "2001"
    ],
    "note": [
      "accessed Oct. 13, 2003)."
    ],
    "title": [
      "Ten Texts on Saquinavir: Its Rapid Rise and Fall",
      "Treatment Access Group"
    ],
    "type": "article-journal",
    "url": [
      "http://www.aidsinfonyc.org/tag/tx"
    ],
    "volume": [
      "16"
    ]
  },
  {
    "citation-number": [
      "10."
    ],
    "date": [
      "2001-06-29"
    ],
    "title": [
      "Interview with Ann Collier"
    ],
    "type": null
  },
  {
    "citation-number": [
      "11."
    ],
    "container-title": [
      "AIDS Action Council, and AIDS Action Baltimore to David Kessler"
    ],
    "date": [
      "1994-06-16"
    ],
    "title": [
      "Letter from Treatment Access Group, Gay Men’s Health Crisis"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Leary",
        "given": "Warren E."
      }
    ],
    "citation-number": [
      "12."
    ],
    "container-title": [
      "New York Times, Apr"
    ],
    "date": [
      "1995"
    ],
    "title": [
      "U.S. Gives Up Right to Control Drug Prices"
    ],
    "type": "article-journal",
    "volume": [
      "12"
    ]
  },
  {
    "citation-number": [
      "13."
    ],
    "container-title": [
      "Gay Men’s Health Crisis’ Treatment Issues"
    ],
    "date": [
      "1994-12"
    ],
    "title": [
      "Inside Roche: An Interview with Jürgen Drews and Whaijen Soo"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Cimons",
        "given": "Marlene"
      },
      {
        "family": "Maugh",
        "given": "Thomas H.",
        "suffix": "II"
      }
    ],
    "citation-number": [
      "14."
    ],
    "container-title": [
      "Los Angeles Times, Feb"
    ],
    "date": [
      "1995"
    ],
    "title": [
      "New Drugs Offer Hope in Battle Against AIDS"
    ],
    "type": "article-journal",
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "Chang",
        "given": "Henry E."
      },
      {
        "family": "Levin",
        "given": "Jules"
      }
    ],
    "citation-number": [
      "15."
    ],
    "container-title": [
      "Gay Men’s Health Crisis’ Treatment Issues, Sept",
      "AIDS Treatment News"
    ],
    "date": [
      "1995",
      "1995-10-06"
    ],
    "title": [
      "Conference Looks at HIV Drug Resistance",
      "Protease Inhibitors and Prevention of Cross Resistance"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "16."
    ],
    "date": [
      "2001-07-06"
    ],
    "title": [
      "Interview with Keith Bragman"
    ],
    "type": null
  },
  {
    "citation-number": [
      "17."
    ],
    "container-title": [
      "Examiner’s Report on Invirase (NDA 20-628), submitted to the Antiviral Drugs Advisory Committee"
    ],
    "date": [
      "1995-11-07"
    ],
    "location": [
      "FDA"
    ],
    "note": [
      "Transcript obtained through FOIA request, Apr. 5, 2002."
    ],
    "pages": [
      "105"
    ],
    "type": "chapter"
  },
  {
    "citation-number": [
      "18."
    ],
    "note": [
      "accessed Oct. 15, 2003)."
    ],
    "title": [
      "Pricing information obtained from the Cipla Web site"
    ],
    "type": null,
    "url": [
      "http://www.cipla"
    ]
  },
  {
    "author": [
      {
        "family": "McGinley",
        "given": "Laurie"
      }
    ],
    "citation-number": [
      "19."
    ],
    "container-title": [
      "Wall Street Journal"
    ],
    "date": [
      "1995-12-08"
    ],
    "title": [
      "First of New Class of AIDS Drugs Get FDA Approval"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "20."
    ],
    "date": [
      "2001-07-17"
    ],
    "title": [
      "Interview with John Leonard"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Smart",
        "given": "Theo"
      }
    ],
    "citation-number": [
      "21."
    ],
    "container-title": [
      "Gay Men’s Health Crisis’ Treatment Issues"
    ],
    "date": [
      "1995-10"
    ],
    "title": [
      "More Clinical Data on Protease Inhibitors"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "given": "F.D.A."
      }
    ],
    "citation-number": [
      "22."
    ],
    "note": [
      "Obtained via FOIA request."
    ],
    "pages": [
      "62"
    ],
    "title": [
      "New Drug Application 20-659 (Norvir"
    ],
    "type": null
  },
  {
    "citation-number": [
      "23."
    ],
    "container-title": [
      "Gay Men’s Health Crisis’ Treatment Issues"
    ],
    "date": [
      "1996-03"
    ],
    "pages": [
      "24",
      "41"
    ],
    "publisher": [
      "Galambos and Sewell, Confronting AIDS"
    ],
    "title": [
      "Three Days that Shook the World"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Waldholz",
        "given": "Michael"
      }
    ],
    "citation-number": [
      "25."
    ],
    "container-title": [
      "Wall Street Journal"
    ],
    "date": [
      "1996-06-14"
    ],
    "title": [
      "Strong Medicine: New Drug ‘Cocktails’ Mark Exciting Turn in the War on AIDS"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "given": "Galambos"
      },
      {
        "family": "Sewell",
        "given": "Confronting A.I.D.S."
      }
    ],
    "citation-number": [
      "26."
    ],
    "pages": [
      "42"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Waldholz",
        "given": "Michael"
      }
    ],
    "citation-number": [
      "27."
    ],
    "container-title": [
      "Wall Street Journal"
    ],
    "date": [
      "1996-06-14"
    ],
    "title": [
      "Strong Medicine: New Drug Cocktails Mark Exciting Turn in the War on AIDS"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Torres",
        "given": "Gabriel"
      },
      {
        "family": "Gilden",
        "given": "Dave"
      }
    ],
    "citation-number": [
      "28."
    ],
    "container-title": [
      "Gay Men’s Health Crisis’ Treatment Issues",
      "Gay Men’s Health Crisis’ Treatment Issues, Apr"
    ],
    "date": [
      "1994-08",
      "1994"
    ],
    "pages": [
      "29",
      "30",
      "50 31",
      "51"
    ],
    "publisher": [
      "Galambos and Sewell, Confronting AIDS",
      "Ibid"
    ],
    "title": [
      "Commentary: Studying Protease Inhibitors",
      "Roy Vagelos on AIDS Treatment and Drug Development"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "given": "Ibid"
      }
    ],
    "citation-number": [
      "32."
    ],
    "pages": [
      "55 165"
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Waldholz"
      }
    ],
    "citation-number": [
      "33."
    ],
    "title": [
      "Strong Medicine"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Tanouye",
        "given": "Elyse"
      }
    ],
    "citation-number": [
      "34."
    ],
    "container-title": [
      "Wall Street Journal"
    ],
    "date": [
      "1996-11-05"
    ],
    "title": [
      "Short Supply: Success of AIDS Drug Has Merck Fighting To Keep Up the Pace"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Fried",
        "given": "Stephen"
      }
    ],
    "citation-number": [
      "35."
    ],
    "container-title": [
      "Washington Post Magazine"
    ],
    "date": [
      "1997-05-18"
    ],
    "pages": [
      "10"
    ],
    "title": [
      "Cocktail Hour"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "36."
    ],
    "container-title": [
      "Oct"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "3"
    ],
    "title": [
      "The Global Alliance for TB Drug Development, “The Economics of TB Drug Development"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Fried",
        "given": "See"
      }
    ],
    "citation-number": [
      "37."
    ],
    "title": [
      "Cocktail Hour"
    ],
    "type": null
  },
  {
    "citation-number": [
      "38."
    ],
    "container-title": [
      "Agouron Pharmaceuticals Inc"
    ],
    "date": [
      "1995"
    ],
    "title": [
      "1998) filings with the Securities and Exchange Commission"
    ],
    "type": "article-journal",
    "volume": [
      "10-K"
    ]
  },
  {
    "citation-number": [
      "39."
    ],
    "container-title": [
      "Vertex Pharmaceuticals Inc"
    ],
    "date": [
      "1992"
    ],
    "title": [
      "filings with the Securities and Exchange Commission"
    ],
    "type": "article-journal",
    "volume": [
      "10-K"
    ]
  },
  {
    "author": [
      {
        "family": "Brown",
        "given": "David"
      }
    ],
    "citation-number": [
      "40."
    ],
    "container-title": [
      "Washington Post"
    ],
    "date": [
      "2001-12-29"
    ],
    "title": [
      "Study Finds Drug-Resistant HIV in Half of Infected Patients"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Maugh",
        "given": "Thomas H.",
        "suffix": "II"
      }
    ],
    "citation-number": [
      "41."
    ],
    "container-title": [
      "Los Angeles Times, Feb"
    ],
    "date": [
      "2001"
    ],
    "title": [
      "AIDS Scientists Fight Rising Tide of Resistance, Risky Behavior"
    ],
    "type": "article-journal",
    "volume": [
      "12"
    ]
  },
  {
    "citation-number": [
      "42."
    ],
    "container-title": [
      "Interviews with Erickson in Aug. 2001 and Mar. 2002 and various e-mail communications"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "literal": "THE FAILED CRUSADE? 1. LeAnn D. Andersen et al."
      },
      {
        "family": "Gina Kolata",
        "particle": "see also"
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "The Oncologist",
      "New York Times"
    ],
    "date": [
      "2002",
      "2001-12-09"
    ],
    "pages": [
      "200–204"
    ],
    "title": [
      "Assessing a Decade of Progress in Cancer Control",
      "Study Sets Off Debate over Mammograms’ Value"
    ],
    "type": "article-journal",
    "volume": [
      "7"
    ]
  },
  {
    "author": [
      {
        "family": "NCI",
        "given": "All",
        "particle": "data drawn from"
      },
      {
        "family": "Review",
        "given": "S.E.E.R.Cancer Statistics"
      },
      {
        "family": "Robert N. Proctor",
        "particle": "see also"
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "How Politics Shapes What We Know and Don’t Know About Cancer"
    ],
    "date": [
      "1973"
    ],
    "pages": [
      "17–34"
    ],
    "title": [
      "Cancer Wars"
    ],
    "type": "chapter",
    "url": [
      "http://www.seer.cancer.gov/;"
    ]
  },
  {
    "author": [
      {
        "family": "Kolata",
        "given": "Gina"
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "New York Times"
    ],
    "date": [
      "1998-05-03"
    ],
    "title": [
      "Hope in the Lab: A Special Report. A Cautious Awe Greets Drugs That Eradicate Tumors in Mice"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "given": "Groopman"
      }
    ],
    "container-title": [
      "NOTES TO PAGES 169",
      "NCI",
      "Ibid"
    ],
    "editor": [
      {
        "family": "Rettig",
        "given": "Richard A."
      },
      {
        "family": "Crusade",
        "given": "Cancer"
      }
    ],
    "location": [
      "The Dread Disease"
    ],
    "note": [
      "Rettig, Cancer Crusade."
    ],
    "pages": [
      "25",
      "52 7",
      "98 272",
      "– 178 8",
      "88–90 9",
      "117 11"
    ],
    "publisher": [
      "James T. Patterson",
      "Cancer and Modern American Culture"
    ],
    "title": [
      "As of late 2002, one of EntreMed’s anti-angiogenesis drugs was in Phase II clinical trials for a rare form of pancreatic cancer. The FDA provided financial support for the trial from a special fund set up to promote drugs for rare diseases. 4. Robert Bazell, Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer",
      "He attributes the phrase to author Susan Love. 5. Unpublished briefing paper by Edward Sausville, director of the Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis",
      "The Thirty Years’ War"
    ],
    "type": "article-journal",
    "volume": [
      "6",
      "10. Ibid"
    ]
  },
  {
    "author": [
      {
        "given": "Ibid"
      },
      {
        "given": "Patterson"
      }
    ],
    "citation-number": [
      "12."
    ],
    "pages": [
      "23",
      "130–31"
    ],
    "title": [
      "The Dread Disease"
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Rettig"
      }
    ],
    "citation-number": [
      "13."
    ],
    "title": [
      "Cancer Crusade"
    ],
    "type": null
  },
  {
    "citation-number": [
      "14."
    ],
    "publisher": [
      "Texas State Historical Association"
    ],
    "title": [
      "Dudley’s role is described in Patterson’s book and in a short entry in the Handbook of Texas Online"
    ],
    "type": "book",
    "url": [
      "http://www.tsha"
    ]
  },
  {
    "citation-number": [
      ".utexas.edu/handbook/online/articles/view/JJ/fja44.html"
    ],
    "note": [
      "accessed Oct. 15, 2003)."
    ],
    "type": null
  },
  {
    "citation-number": [
      "15."
    ],
    "container-title": [
      "in midtwentieth-century America. See Patterson, The Dread Disease"
    ],
    "pages": [
      "106–8"
    ],
    "publisher": [
      "Norman Baker of Iowa"
    ],
    "title": [
      "advertising that “cancer is curable,” peddled his arsenic compounds through the mails. He eventually served four years in Leavenworth for mail fraud. Harry Hoxsey attracted thousands of dying patients to his Dallas clinic for a treatment that combined potassium iodide, red clover, poke root, prickly ash bark, and other herbal aids. It took the FDA more than two decades of litigation before it shut him down in 1960. The two were only the most famous of dozens of charlatans who “worked the cancer angle"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Bazell",
        "given": "Her-2"
      }
    ],
    "citation-number": [
      "16."
    ],
    "pages": [
      "22–23"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Goodman",
        "given": "Jordan"
      },
      {
        "family": "Walsh",
        "given": "Vivien"
      }
    ],
    "citation-number": [
      "17."
    ],
    "pages": [
      "11–12"
    ],
    "title": [
      "The Story of Taxol: Nature and Politics in the Pursuit of an Anti-Cancer Drug"
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Patterson"
      }
    ],
    "citation-number": [
      "18."
    ],
    "date": [
      "195"
    ],
    "pages": [
      "145–47,"
    ],
    "title": [
      "The Dread Disease"
    ],
    "type": null
  },
  {
    "citation-number": [
      "19."
    ],
    "pages": [
      "196"
    ],
    "title": [
      "From a 1964 interview quoted in Patterson, The Dread Disease"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Schepartz",
        "given": "Saul A."
      }
    ],
    "citation-number": [
      "20."
    ],
    "container-title": [
      "Division of Cancer Treatment and Diagnosis, NCI; reprinted in Cooperative Approaches to Research and Development of Orphan Drugs",
      "Van Woert and Eunyong Chung"
    ],
    "date": [
      "1985"
    ],
    "editor": [
      {
        "family": "Melvin H",
        "particle": "ed."
      }
    ],
    "location": [
      "New York"
    ],
    "pages": [
      "75"
    ],
    "publisher": [
      "Alan R. Liss Inc"
    ],
    "title": [
      "The National Cancer Institute’s Drug Development Program"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "given": "Proctor"
      }
    ],
    "citation-number": [
      "21."
    ],
    "pages": [
      "36–48"
    ],
    "title": [
      "Cancer Wars"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Kluger",
        "given": "Richard"
      }
    ],
    "citation-number": [
      "22."
    ],
    "pages": [
      "135–62"
    ],
    "title": [
      "Ashes to Ashes: America’s Hundred-Year Cigarette War, the Public Health, and the Unabashed Triumph of Philip Morris"
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Kluger"
      }
    ],
    "citation-number": [
      "23."
    ],
    "pages": [
      "143–44"
    ],
    "title": [
      "Ashes to Ashes"
    ],
    "type": null
  },
  {
    "citation-number": [
      "24."
    ],
    "container-title": [
      "chapter 5, “‘Doubt Is Our Product’"
    ],
    "publisher": [
      "Trade Association Science.”"
    ],
    "title": [
      "See Kluger for a full history of the scientific battles over cigarette smoking and cancer. For a broader discussion of industry-funded science, see Proctor, Cancer Wars, esp"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Weinberg",
        "given": "Robert A."
      }
    ],
    "citation-number": [
      "25."
    ],
    "pages": [
      "31"
    ],
    "title": [
      "Racing to the Beginning of the Road: The Search for the Origin of Cancer"
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Weinberg"
      }
    ],
    "citation-number": [
      "26."
    ],
    "pages": [
      "57"
    ],
    "title": [
      "Racing to the Beginning of the Road"
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Panem"
      }
    ],
    "citation-number": [
      "27."
    ],
    "note": [
      "At the outset of the biotechnology"
    ],
    "pages": [
      "12"
    ],
    "title": [
      "The Interferon Crusade"
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Rettig"
      }
    ],
    "citation-number": [
      "29."
    ],
    "pages": [
      "156, 218"
    ],
    "title": [
      "Cancer Crusade"
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Ibid"
      }
    ],
    "citation-number": [
      "30."
    ],
    "pages": [
      "255–56"
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Proctor"
      }
    ],
    "citation-number": [
      "31."
    ],
    "pages": [
      "137"
    ],
    "title": [
      "Cancer Wars"
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Ibid"
      }
    ],
    "citation-number": [
      "32."
    ],
    "pages": [
      "57–61 33",
      "133"
    ],
    "publisher": [
      "Ibid"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "given": "Weinberg"
      }
    ],
    "citation-number": [
      "34."
    ],
    "pages": [
      "83–84"
    ],
    "title": [
      "Racing to the Beginning of the Road"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Vincent T",
        "given": "Interview",
        "particle": "with"
      }
    ],
    "citation-number": [
      "35."
    ],
    "date": [
      "2002-08-12"
    ],
    "publisher": [
      "director of the Yale University Cancer Center"
    ],
    "title": [
      "De Vita (director of NCI from 1980 to 1988"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Waldholz",
        "given": "Michael"
      }
    ],
    "citation-number": [
      "36."
    ],
    "pages": [
      "278 37",
      "43 38",
      "286"
    ],
    "publisher": [
      "Ibid",
      "Ibid"
    ],
    "title": [
      "Curing Cancer"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "given": "Panem"
      }
    ],
    "citation-number": [
      "39."
    ],
    "pages": [
      "35–74"
    ],
    "title": [
      "The Interferon Crusade"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Rosenberg",
        "given": "B."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "40."
    ],
    "container-title": [
      "Nature, Feb"
    ],
    "date": [
      "1965"
    ],
    "pages": [
      "698–99"
    ],
    "title": [
      "Inhibition of Cell Division in Escherichia Coli by Electrolysis Products from a Platinum Electrode"
    ],
    "type": "article-journal",
    "volume": [
      "13"
    ]
  },
  {
    "author": [
      {
        "family": "Allen",
        "given": "Arthur"
      },
      {
        "family": "Einhorn",
        "given": "Lawrence H."
      }
    ],
    "citation-number": [
      "41."
    ],
    "container-title": [
      "Salon.com"
    ],
    "date": [
      "1999-07-29",
      "2003-10-15"
    ],
    "note": [
      "unpublished paper, Indiana University Medical Center); and “NCI Role in the Discovery and Development of Marketed Anticancer Drugs” (unpublished paper, NCI). 42."
    ],
    "pages": [
      "56–69"
    ],
    "publisher": [
      "Goodman and Walsh, The Story of Taxol"
    ],
    "title": [
      "Triumph of the Cure",
      "Update in Testicular Cancer"
    ],
    "type": "article-journal",
    "url": [
      "http://www.salon.com/health/feature/1999/07/29/"
    ]
  },
  {
    "author": [
      {
        "family": "Schiff",
        "given": "P.B."
      },
      {
        "family": "Fant",
        "given": "J."
      },
      {
        "family": "Horwitz",
        "given": "S.B."
      }
    ],
    "citation-number": [
      "43."
    ],
    "container-title": [
      "Nature, Feb"
    ],
    "date": [
      "1979"
    ],
    "pages": [
      "665–67"
    ],
    "title": [
      "Promotion of Microtubule Assembly In Vitro by Taxol"
    ],
    "type": "article-journal",
    "volume": [
      "22"
    ]
  },
  {
    "author": [
      {
        "given": "Goodman"
      },
      {
        "given": "Walsh"
      }
    ],
    "citation-number": [
      "44."
    ],
    "pages": [
      "115–19"
    ],
    "title": [
      "The Story of Taxol"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Chase",
        "given": "Marilyn"
      }
    ],
    "citation-number": [
      "45."
    ],
    "container-title": [
      "Wall Street Journal, Apr"
    ],
    "date": [
      "1991"
    ],
    "title": [
      "Clashing Priorities: A New Cancer Drug May Extend Lives"
    ],
    "type": "article-journal",
    "volume": [
      "9"
    ]
  },
  {
    "author": [
      {
        "given": "Goodman"
      },
      {
        "given": "Walsh"
      }
    ],
    "citation-number": [
      "46."
    ],
    "pages": [
      "158"
    ],
    "title": [
      "The Story of Taxol"
    ],
    "type": null
  },
  {
    "citation-number": [
      "47."
    ],
    "date": [
      "Dec",
      "2002"
    ],
    "publisher": [
      "Rubinfeld left Bristol"
    ],
    "title": [
      "Interview with Joseph Rubinfeld"
    ],
    "type": "book",
    "volume": [
      "3"
    ]
  },
  {
    "author": [
      {
        "family": "Amgen",
        "given": "Myers Squibb",
        "particle": "to help start"
      }
    ],
    "container-title": [
      "48. Hearing of the Regulation, Business Opportunity, and Energy Subcommittee of the House Small Business Committee, 103rd Cong., 1st sess"
    ],
    "date": [
      "1993-01-25",
      "2002-07-16"
    ],
    "note": [
      "Ibid. 50. Ibid. 51. Peter R. Dolan, “Letter to Employees,” Bristol-Myers Squibb, June 6, 2002,",
      "accessed June 15, 2002). 52. Interview with Richard Klausner,"
    ],
    "pages": [
      "49"
    ],
    "title": [
      "In 2002 he was chief executive officer of SuperGen, which is seeking to commercialize anticancer drugs discovered at the Houston-based Stehlin Foundation, a nonprofit institute that has screened drug candidates for NCI for many years"
    ],
    "type": "chapter",
    "url": [
      "http://www.bms.com"
    ]
  },
  {
    "citation-number": [
      "53."
    ],
    "title": [
      "Pharmaceutical Research and Manufacturers Association, “2001 Survey: New Medicines in Development for Cancer"
    ],
    "type": null,
    "url": [
      "http://www.phrma.org/"
    ]
  },
  {
    "date": [
      "2003-10-15",
      "55"
    ],
    "issue": [
      "pdf"
    ],
    "note": [
      "Also, interview with Dennis Slamon, Feb. 7, 2003."
    ],
    "pages": [
      "63",
      "35–52"
    ],
    "title": [
      "54. Quoted in Groopman, “The Thirty Years’ War",
      "Klausner interview. 56. This account of the development of Herceptin is drawn largely from Bazell, Her-2"
    ],
    "type": "interview",
    "volume": [
      "01"
    ]
  },
  {
    "citation-number": [
      "274"
    ],
    "container-title": [
      "NOTES TO PAGES 194"
    ],
    "note": [
      "Bazell, Her-2; Slamon interview."
    ],
    "pages": [
      "– 201 57"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "See",
        "given": "for instance"
      },
      {
        "family": "Marsa",
        "given": "Linda"
      }
    ],
    "citation-number": [
      "58."
    ],
    "pages": [
      "199–207"
    ],
    "title": [
      "Prescription for Profits: How the Pharmaceutical Industry Bankrolled the Holy Marriage between Science and Business"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "McCoy",
        "given": "Charles"
      }
    ],
    "citation-number": [
      "59."
    ],
    "container-title": [
      "Wall Street Journal"
    ],
    "date": [
      "1995-07-12"
    ],
    "title": [
      "Genentech’s New CEO Seeks Clean Slate—Levinson Takes Charge at Biotech Firm after Raab’s Ouster"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "given": "Bazell"
      }
    ],
    "citation-number": [
      "60."
    ],
    "pages": [
      "44–47 61"
    ],
    "publisher": [
      "Slamon interview"
    ],
    "title": [
      "Her-2"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "See",
        "given": "for instance"
      },
      {
        "family": "Horowitz",
        "given": "Craig"
      }
    ],
    "citation-number": [
      "62."
    ],
    "date": [
      "1998-05-25"
    ],
    "location": [
      "New York"
    ],
    "pages": [
      "67–71"
    ],
    "title": [
      "The Cancer Killer"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Bazell",
        "given": "Her-2"
      }
    ],
    "citation-number": [
      "63."
    ],
    "pages": [
      "72"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Parker-Pope",
        "given": "Tara"
      }
    ],
    "citation-number": [
      "64."
    ],
    "container-title": [
      "Wall Street Journal"
    ],
    "date": [
      "1998-05-15"
    ],
    "title": [
      "Revlon Is a Cancer Drug’s Unlikely Benefactor"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "65."
    ],
    "note": [
      "accessed Oct. 15, 2003)."
    ],
    "title": [
      "For the trial’s summary, see Herceptin’s label, FDA"
    ],
    "type": null,
    "url": [
      "http://www.fda.gov/"
    ]
  },
  {
    "author": [
      {
        "family": "interview",
        "given": "Slamon"
      }
    ],
    "citation-number": [
      "66."
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Vogel",
        "given": "C.L."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "67."
    ],
    "container-title": [
      "Oncology"
    ],
    "date": [
      "2001"
    ],
    "note": [
      "Slamon interview."
    ],
    "pages": [
      "2",
      "37–42"
    ],
    "title": [
      "First-Line Herceptin Monotherapy in Metastatic Breast Cancer"
    ],
    "type": "article-journal",
    "volume": [
      "61"
    ]
  },
  {
    "citation-number": [
      "68."
    ],
    "container-title": [
      "San Francisco Chronicle"
    ],
    "date": [
      "2001",
      "2002-06-28"
    ],
    "title": [
      "Herceptin generated $346.6 million in sales for Genentech in",
      "See Bernadette Tansey, “Judge Rules Against Genentech in Chiron Patent Suit"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "V. Craig Jordan",
        "given": "Interview",
        "particle": "with"
      },
      {
        "family": "V. Craig Jordan",
        "given": "See",
        "particle": "also"
      }
    ],
    "citation-number": [
      "69."
    ],
    "container-title": [
      "Sept",
      "Scientific American"
    ],
    "date": [
      "2002",
      "1998-10"
    ],
    "pages": [
      "60–67"
    ],
    "title": [
      "Designer Estrogens"
    ],
    "type": "article-journal",
    "volume": [
      "11"
    ]
  },
  {
    "author": [
      {
        "family": "Kolata",
        "given": "Gina"
      },
      {
        "family": "Fisher",
        "given": "Lawrence M."
      }
    ],
    "citation-number": [
      "70."
    ],
    "container-title": [
      "New York Times, Sept"
    ],
    "date": [
      "1998"
    ],
    "title": [
      "Drugs to Fight Breast Cancer Near Approval"
    ],
    "type": "article-journal",
    "volume": [
      "3"
    ]
  },
  {
    "author": [
      {
        "family": "interview",
        "given": "Jordan"
      }
    ],
    "citation-number": [
      "71."
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Wade",
        "given": "Nicholas"
      }
    ],
    "citation-number": [
      "72."
    ],
    "container-title": [
      "New York Times"
    ],
    "date": [
      "2001-05-08"
    ],
    "title": [
      "Powerful Anti-Cancer Drug Emerges from Basic Biology"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Waalen",
        "given": "Jill"
      }
    ],
    "citation-number": [
      "73."
    ],
    "container-title": [
      "Howard Hughes Medical Institute Bulletin"
    ],
    "date": [
      "2001-12"
    ],
    "pages": [
      "10–15"
    ],
    "title": [
      "Gleevec’s Glory Days"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "74."
    ],
    "date": [
      "2003-01-17"
    ],
    "title": [
      "Interview with Brian Druker"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Wade",
        "given": "Druker",
        "particle": "interview. See also"
      },
      {
        "family": "Moore",
        "given": "Stephen D."
      }
    ],
    "citation-number": [
      "75."
    ],
    "container-title": [
      "Wall Street Journal"
    ],
    "date": [
      "2000-06-06"
    ],
    "title": [
      "Powerful Anti-Cancer Drug”; Waalen, “Gleevec’s Glory Days”",
      "Blood Test: News about Leukemia Unexpectedly Puts Novartis on the Spot"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "given": "Moore"
      },
      {
        "family": "G. D. Demetri",
        "given": "See",
        "particle": "also"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "76."
    ],
    "container-title": [
      "New England Journal of Medicine"
    ],
    "date": [
      "2002-08-15"
    ],
    "note": [
      "The financial disclosure statements in the paper do not include NCI."
    ],
    "pages": [
      "472–80"
    ],
    "title": [
      "Blood Test",
      "Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Druker",
        "given": "Brian J."
      },
      {
        "others": true
      },
      {
        "family": "Druker",
        "given": "Also Brian J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "77."
    ],
    "container-title": [
      "New England Journal of Medicine, Apr"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "1031–37"
    ],
    "title": [
      "Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia",
      "Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the"
    ],
    "type": "article-journal",
    "volume": [
      "5"
    ]
  },
  {
    "container-title": [
      "NOTES TO PAGES 201",
      "Druker interview. 79. “ODAC Advice Poses Challenge to FDA: Would Iressa Approval Erode Standards?” The Cancer Letter",
      "New England Journal of Medicine, Apr"
    ],
    "date": [
      "2001",
      "2002-11-08"
    ],
    "pages": [
      "1038–42",
      "– 219 275 78"
    ],
    "title": [
      "Philadelphia Chromosome"
    ],
    "type": "article-journal",
    "volume": [
      "5"
    ]
  },
  {
    "citation-number": [
      "80."
    ],
    "container-title": [
      "The Cancer Letter"
    ],
    "date": [
      "2002-01-04"
    ],
    "title": [
      "FDA Says Data Insufficient to Evaluate C225 Application"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "81."
    ],
    "container-title": [
      "Business Week"
    ],
    "date": [
      "2001-07-09"
    ],
    "pages": [
      "95–102 82"
    ],
    "publisher": [
      "Ibid"
    ],
    "title": [
      "For a detailed account of Erbitux’s early development, see Catherine Arnst, “The Birth of a Cancer Drug"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Anand",
        "given": "Geeta"
      }
    ],
    "citation-number": [
      "83."
    ],
    "container-title": [
      "Wall Street Journal, Sept"
    ],
    "date": [
      "2002"
    ],
    "title": [
      "History and Science: In Waksal’s Past: Repeated Ousters"
    ],
    "type": "article-journal",
    "volume": [
      "27"
    ]
  },
  {
    "author": [
      {
        "given": "Arnst"
      }
    ],
    "citation-number": [
      "84."
    ],
    "pages": [
      "98"
    ],
    "title": [
      "The Birth of a Cancer Drug"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Gillis",
        "given": "Justin"
      }
    ],
    "citation-number": [
      "85."
    ],
    "container-title": [
      "The Cancer Letter"
    ],
    "date": [
      "2002-06-30",
      "2002-10-18"
    ],
    "genre": [
      "Washington Post,"
    ],
    "pages": [
      "5"
    ],
    "title": [
      "A Hospital’s Conflict of Interest: Patients Weren’t Told of Stake in Cancer Drug",
      "Mendelsohn Defends ImClone’s Actions and His Role in Development of C225"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "86."
    ],
    "date": [
      "2002-01-04"
    ],
    "title": [
      "The Cancer Letter"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Moss",
        "given": "Ralph W."
      }
    ],
    "citation-number": [
      "87."
    ],
    "container-title": [
      "Cancer Decisions Newsletter"
    ],
    "date": [
      "2002-07-29"
    ],
    "pages": [
      "88",
      "3"
    ],
    "publisher": [
      "“Mendolsohn Defends ImClone’s Actions,”"
    ],
    "title": [
      "Report from ASCO: Trials and Tribulations of a New Cancer Drug"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "89."
    ],
    "note": [
      "Druker interview."
    ],
    "type": "interview"
  },
  {
    "author": [
      {
        "family": "interview",
        "given": "Jordan"
      }
    ],
    "citation-number": [
      "90."
    ],
    "type": null
  },
  {
    "citation-number": [
      "91."
    ],
    "date": [
      "2002-12-12"
    ],
    "title": [
      "Interview with Ellen Vitetta"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "TOO!",
        "given": "M.E."
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "See esp"
    ],
    "pages": [
      "98–120"
    ],
    "title": [
      "1. The best account I’ve found of the so-called Prontosil affair is contained in Frank Ryan, Forgotten Plague"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Silverman",
        "given": "Milton"
      },
      {
        "family": "Lee",
        "given": "Philip R."
      },
      {
        "given": "Pills"
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Profits, and Politics"
    ],
    "pages": [
      "86"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Temin",
        "given": "Peter"
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Bell Journal of Economics"
    ],
    "date": [
      "1979"
    ],
    "issue": [
      "2"
    ],
    "note": [
      "See also Jane S. Smith, Patenting the Sun: Polio and the Salk Vaccine."
    ],
    "pages": [
      "429–46"
    ],
    "title": [
      "Technology, Regulation, and Market Structure in the Modern Pharmaceutical Industry"
    ],
    "type": "article-journal",
    "volume": [
      "10"
    ]
  },
  {
    "author": [
      {
        "given": "Temin"
      }
    ],
    "citation-number": [
      "4."
    ],
    "pages": [
      "438"
    ],
    "title": [
      "Technology, Regulation, and Market Structure"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Harris",
        "given": "Richard"
      }
    ],
    "citation-number": [
      "5."
    ],
    "pages": [
      "8 6",
      "79"
    ],
    "publisher": [
      "Ibid"
    ],
    "title": [
      "The Real Voice"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "given": "Silverman"
      },
      {
        "family": "Lee",
        "given": "Pills"
      }
    ],
    "citation-number": [
      "7."
    ],
    "pages": [
      "4–5"
    ],
    "title": [
      "Profits, and Politics"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Fuchs",
        "given": "Victor R."
      },
      {
        "family": "Sox",
        "given": "Harold C.",
        "suffix": "Jr"
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Health Affairs"
    ],
    "date": [
      "Sept./Oct. 2001"
    ],
    "pages": [
      "35"
    ],
    "title": [
      "Physicians’ Views of the Relative Importance of Thirty Medical Innovations"
    ],
    "type": "article-journal",
    "volume": [
      "20"
    ]
  },
  {
    "author": [
      {
        "family": "Kessler",
        "given": "David A."
      },
      {
        "family": "Rose",
        "given": "Janet L."
      },
      {
        "family": "Temple",
        "given": "Robert J."
      },
      {
        "family": "Schapiro",
        "given": "Renie"
      },
      {
        "family": "Griffin",
        "given": "Joseph P."
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "The New England Journal of Medicine"
    ],
    "date": [
      "1994-11-17"
    ],
    "pages": [
      "1350–53"
    ],
    "title": [
      "Therapeutic-Class Wars: Drug Promotion in a Competitive Marketplace"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "given": "N.I.H."
      }
    ],
    "citation-number": [
      "10."
    ],
    "date": [
      "2000"
    ],
    "title": [
      "NIH Contributions to Pharmaceutical Development, Case Study Analysis of the Top-Selling Drugs, Office of Science Policy, Feb"
    ],
    "type": null
  },
  {
    "citation-number": [
      "11."
    ],
    "container-title": [
      "Mar"
    ],
    "date": [
      "2001"
    ],
    "title": [
      "Interview with George Sachs"
    ],
    "type": "article-journal",
    "volume": [
      "29"
    ]
  },
  {
    "author": [
      {
        "family": "Blumenthal",
        "given": "David"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "12."
    ],
    "container-title": [
      "276 NOTES TO PAGES",
      "New England Journal of Medicine"
    ],
    "date": [
      "Dec"
    ],
    "pages": [
      "219 – 227"
    ],
    "title": [
      "Participation of Life-Science Faculty in Research Relationships with Industry"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Parent",
        "given": "Kevin"
      }
    ],
    "citation-number": [
      "13."
    ],
    "container-title": [
      "Postgraduate Medicine"
    ],
    "date": [
      "1994-11-01"
    ],
    "pages": [
      "53"
    ],
    "type": "article-journal",
    "volume": [
      "96"
    ]
  },
  {
    "author": [
      {
        "family": "Foundation",
        "given": "Henry J.Kaiser Family"
      }
    ],
    "citation-number": [
      "14."
    ],
    "date": [
      "2001-11"
    ],
    "title": [
      "Prescription Drug Trends"
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "N.I.H."
      }
    ],
    "citation-number": [
      "15."
    ],
    "pages": [
      "12–13"
    ],
    "title": [
      "NIH Contributions to Pharmaceutical Development"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Harris",
        "given": "Gardiner"
      }
    ],
    "citation-number": [
      "16."
    ],
    "container-title": [
      "Wall Street Journal"
    ],
    "date": [
      "2002-06-06"
    ],
    "title": [
      "Prilosec’s Maker Switches Users to Nexium, Thwarting Generics"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "interview",
        "given": "Sachs"
      }
    ],
    "citation-number": [
      "17."
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Harris"
      }
    ],
    "citation-number": [
      "18."
    ],
    "title": [
      "Prilosec’s Maker"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Hall",
        "given": "Stephen"
      }
    ],
    "citation-number": [
      "19."
    ],
    "container-title": [
      "New York Times Magazine, Mar"
    ],
    "date": [
      "2001"
    ],
    "title": [
      "The Claritin Effect: Prescription for Profit"
    ],
    "type": "article-journal",
    "volume": [
      "11"
    ]
  },
  {
    "author": [
      {
        "family": "Harris",
        "given": "Gardiner"
      },
      {
        "family": "Scott Hensley",
        "given": "See",
        "particle": "also"
      }
    ],
    "citation-number": [
      "20."
    ],
    "container-title": [
      "Wall Street Journal",
      "Wall Street Journal, Mar"
    ],
    "date": [
      "2002-03-21",
      "2002"
    ],
    "title": [
      "As Blockbuster Claritin Goes Generic, Schering-Plough Pushes a Close Sibling",
      "More Than Ads, Drug Makers Rely on Sales Representatives"
    ],
    "type": "article-journal",
    "volume": [
      "14"
    ]
  },
  {
    "author": [
      {
        "family": "Pollack",
        "given": "Andrew"
      }
    ],
    "citation-number": [
      "21."
    ],
    "container-title": [
      "New York Times, Apr"
    ],
    "date": [
      "2000"
    ],
    "title": [
      "Battling Searle, University Gets Broad Patent for New Painkiller"
    ],
    "type": "article-journal",
    "volume": [
      "12"
    ]
  },
  {
    "author": [
      {
        "family": "Harris",
        "given": "Gardiner"
      }
    ],
    "citation-number": [
      "22."
    ],
    "container-title": [
      "Wall Street Journal"
    ],
    "date": [
      "2001-01-10"
    ],
    "title": [
      "When Its Patents Expired, Merck Didn’t Merge—It Found New Drugs"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Research",
        "given": "Pharmaceutical"
      },
      {
        "family": "Association",
        "given": "Manufacturers"
      }
    ],
    "citation-number": [
      "23."
    ],
    "container-title": [
      "press release, Mar"
    ],
    "date": [
      "2002"
    ],
    "title": [
      "Pharmaceutical Industry Honors Discoverers of Celebrex"
    ],
    "type": "article-journal",
    "volume": [
      "25"
    ]
  },
  {
    "author": [
      {
        "family": "see",
        "given": "for instance"
      },
      {
        "family": "Matheson",
        "given": "A.J."
      },
      {
        "family": "Figgitt",
        "given": "D.P."
      },
      {
        "family": "R. Hawel",
        "particle": "see also"
      },
      {
        "others": true
      }
    ],
    "container-title": [
      "Drugs",
      "International Journal of Clinical Pharmacology and Therapeutics"
    ],
    "date": [
      "2001",
      "2003-04"
    ],
    "issue": [
      "6"
    ],
    "note": [
      "See for instance the special supplement to the American Journal of Medicine, Mar. 30, 1998."
    ],
    "pages": [
      "833–65",
      "153–64 24"
    ],
    "title": [
      "Numerous studies in the academic literature have shown that Cox-2 inhibitors are no better than ibuprofen, diclofenac, and naproxen sodium for reducing aches and pains",
      "Rofecoxib: A Review of Its Use in the Management of Osteoarthritis, Acute Pain and Rheumatoid Arthritis",
      "Comparison of the Efficacy and Tolerability of Dexibuprofen and Celecoxib in the Treatment of Osteoarthritis of the Hip"
    ],
    "type": "article-journal",
    "volume": [
      "61",
      "4"
    ]
  },
  {
    "author": [
      {
        "family": "Neus",
        "given": "Elizabeth"
      }
    ],
    "citation-number": [
      "25."
    ],
    "container-title": [
      "Chicago Sun-Times",
      "Business Week, Mar"
    ],
    "date": [
      "1998",
      "1999"
    ],
    "pages": [
      "104"
    ],
    "title": [
      "New Arthritis Relief: Pain-Killers Promise to Be Tummy-Friendly",
      "Conquering Pain"
    ],
    "type": "article-journal",
    "volume": [
      "Oct. 28",
      "1"
    ]
  },
  {
    "citation-number": [
      "27."
    ],
    "container-title": [
      "Washington Post"
    ],
    "date": [
      "1999-05-22"
    ],
    "title": [
      "FDA Approves Pain Reliever with Fewer Side Effects"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Levenstein",
        "given": "Susan"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "28."
    ],
    "container-title": [
      "“Association of Upper Gastrointestinal Toxicity of Nonsteroidal NOTES TO PAGES",
      "Journal of the American Medical Association"
    ],
    "date": [
      "1999-06-30",
      "1999-01-06"
    ],
    "editor": [
      {
        "family": "Mac-Donald",
        "given": "T.M."
      },
      {
        "others": true
      }
    ],
    "pages": [
      "228 – 234 277"
    ],
    "title": [
      "Centers for Disease Control and Prevention, National Vital Statistics Report 47",
      "Stress and Peptic Ulcer Disease"
    ],
    "type": "article-journal"
  },
  {
    "container-title": [
      "British Medical Journal"
    ],
    "date": [
      "1997-11-22"
    ],
    "title": [
      "Anti-inflammatory Drugs with Continued Exposure: Cohort Study"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Lichtenstein",
        "given": "David R."
      },
      {
        "family": "Wolfe",
        "given": "M.Michael"
      }
    ],
    "citation-number": [
      "29."
    ],
    "container-title": [
      "The Journal of the American Medical Association, Sept"
    ],
    "date": [
      "2000"
    ],
    "pages": [
      "1297–99"
    ],
    "title": [
      "COX-2-selective NSAIDS: New and Improved?"
    ],
    "type": "article-journal",
    "volume": [
      "13"
    ]
  },
  {
    "author": [
      {
        "family": "FitzGerald",
        "given": "Garret A."
      },
      {
        "family": "Patrono",
        "given": "Carlo"
      }
    ],
    "citation-number": [
      "30."
    ],
    "container-title": [
      "The New England Journal of Medicine"
    ],
    "date": [
      "2001-08-09"
    ],
    "pages": [
      "433–42"
    ],
    "title": [
      "The Coxibs, Selective Inhibitors of Cyclooxygenase-2"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Petersen",
        "given": "Melody"
      }
    ],
    "citation-number": [
      "31."
    ],
    "container-title": [
      "New York Times"
    ],
    "date": [
      "2001-05-22"
    ],
    "title": [
      "Doubts Are Raised on the Safety of Two Popular Arthritis Drugs"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "given": "F.D.A."
      }
    ],
    "citation-number": [
      "32."
    ],
    "container-title": [
      "press release, Apr"
    ],
    "date": [
      "2002"
    ],
    "title": [
      "FDA Approves New Indication and Label Changes for the Arthritis Drug, Vioxx"
    ],
    "type": "article-journal",
    "volume": [
      "11"
    ]
  },
  {
    "author": [
      {
        "family": "Okie",
        "given": "Susan"
      }
    ],
    "citation-number": [
      "33."
    ],
    "container-title": [
      "Washington Post"
    ],
    "date": [
      "2001-08-05"
    ],
    "title": [
      "Missing Data on Celebrex: Full Study Altered Picture of Drug"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Jüni",
        "given": "Peter"
      },
      {
        "family": "Rutjes",
        "given": "Anne"
      },
      {
        "family": "Dieppe",
        "given": "Paul"
      }
    ],
    "citation-number": [
      "34."
    ],
    "container-title": [
      "British Medical Journal"
    ],
    "date": [
      "2002-06-01"
    ],
    "pages": [
      "1287–88"
    ],
    "title": [
      "Are Selective Cox-2 Inhibitors Superior to Traditional Nonsteroidal Anti-inflammatory Drugs?"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Foundation",
        "given": "Henry J.Kaiser Family"
      }
    ],
    "citation-number": [
      "35."
    ],
    "container-title": [
      "Nov"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "31"
    ],
    "title": [
      "Prescription Drug Trends: A Chartbook Update"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Angell",
        "given": "Marcia"
      }
    ],
    "citation-number": [
      "36."
    ],
    "container-title": [
      "The New England Journal of Medicine"
    ],
    "date": [
      "2000-06-22",
      "1904"
    ],
    "pages": [],
    "title": [
      "The Pharmaceutical Industry: To Whom Is It Accountable?"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Joan Raymond",
        "given": "David Noonan",
        "particle": "with"
      },
      {
        "family": "Gesalman",
        "given": "Anne Belli"
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Newsweek, Sept"
    ],
    "date": [
      "2000"
    ],
    "pages": [
      "22"
    ],
    "title": [
      "Why Drugs Cost So Much"
    ],
    "type": "article-journal",
    "volume": [
      "25"
    ]
  },
  {
    "author": [
      {
        "family": "Foundation",
        "given": "Henry J.Kaiser Family"
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Prescription Drug Expenditures in 2001: Another Year of Escalating"
    ],
    "date": [
      "2001-11"
    ],
    "title": [
      "Prescription Drug Trends: A Chartbook Update",
      "See also National Institute for Health Care Management"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Costs",
        "given": "Apr"
      },
      {
        "family": "Foundation",
        "given": "Henry J.Kaiser Family"
      },
      {
        "family": "Zhan",
        "given": "Chunliu"
      },
      {
        "others": true
      },
      {
        "family": "Henry",
        "given": "J."
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Journal of the American Medical Association",
      "Prescription Drug Trends; see also Pharmaceutical Research and Manufacturers Association, “Annual Report"
    ],
    "date": [
      "2002",
      "2000-11",
      "2001-12-12",
      "2001"
    ],
    "genre": [
      "Understanding Government,"
    ],
    "pages": [
      "4",
      "2823–29 6",
      "13 7"
    ],
    "publisher": [
      "Thomas Maeder"
    ],
    "title": [
      "and National Institute for Health Care Management, Prescription Drugs and Mass Media Advertising",
      "Prescription Drug Trends",
      "Potentially Inappropriate Medication Use in the Community-Dwelling Elderly",
      "Kaiser Family Foundation",
      "The FDA Meets the Twenty-first Century"
    ],
    "type": "article-journal",
    "url": [
      "http://www.understandinggovernment.org/maeder.html"
    ]
  },
  {
    "note": [
      "accessed Mar. 25, 2003)."
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "See",
        "given": "for instance"
      },
      {
        "family": "Adams",
        "given": "Chris"
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Wall Street Journal",
      "Wall Street Journal, Mar",
      "New York Times"
    ],
    "date": [
      "2001-05-14",
      "2002",
      "2002-10-01"
    ],
    "title": [
      "Doctors ‘Dine n’ Dash’ in Style, As Drug Firms Pick Up the Tab",
      "Scott Hensley, “More Than Ads, Drug Makers Rely on Sales Representatives",
      "Robert Pear, “Drug Industry Is Told to Stop Gifts to Doctors"
    ],
    "type": "article-journal",
    "volume": [
      "14"
    ]
  },
  {
    "author": [
      {
        "given": "Harris"
      }
    ],
    "citation-number": [
      "9."
    ],
    "pages": [
      "76"
    ],
    "title": [
      "The Real Voice"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Holmer",
        "given": "Alan F."
      }
    ],
    "citation-number": [
      "10."
    ],
    "container-title": [
      "USA Today"
    ],
    "date": [
      "2002-05-31"
    ],
    "title": [
      "Innovation Is Key Mission"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "11."
    ],
    "container-title": [
      "Jay Olshansky, Oct"
    ],
    "date": [
      "2002"
    ],
    "title": [
      "Life expectancy statistics are available on the Centers for Disease Control Web site, http://www.cdc.gov; e-mail communication from S"
    ],
    "type": "article-journal",
    "volume": [
      "16"
    ]
  },
  {
    "citation-number": [
      "12."
    ],
    "date": [
      "2002-10"
    ],
    "publisher": [
      "Runner’s World"
    ],
    "title": [
      "See also National Association for Sport and"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Education",
        "given": "Physical"
      },
      {
        "family": "Epstein",
        "given": "Samuel S."
      },
      {
        "family": "DiMasi",
        "given": "Joseph A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "15."
    ],
    "container-title": [
      "Journal of Health Economics"
    ],
    "date": [
      "2001-10",
      "1991",
      "2001-11-30"
    ],
    "editor": [
      {
        "family": "Bailey",
        "given": "See Ronald"
      }
    ],
    "note": [
      "Tufts Center for the Study of Drug Development, “Tufts Center for the Study of Drug Development Pegs Cost of New Prescription Medicine at $802 Million,” press release,"
    ],
    "pages": [
      "13",
      "107–42 16"
    ],
    "title": [
      "The Shape of the Nation Report",
      "Global Warming and Other Eco-Myths: How the Environmental Movement Uses False Science to Scare Us to Death",
      "The Politics of Cancer Revisited. 14. Holmer, “Innovation Is Key Mission",
      "Cost of Innovation in the Pharmaceutical Industry"
    ],
    "type": "article-journal",
    "volume": [
      "10"
    ]
  },
  {
    "citation-number": [
      "17."
    ],
    "title": [
      "Data provided by the Division of AIDS, NIAID"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Office",
        "given": "Government Accounting"
      }
    ],
    "citation-number": [
      "18."
    ],
    "container-title": [
      "Report to Congressional Requesters"
    ],
    "date": [
      "1999-09"
    ],
    "title": [
      "NIH Clinical Trials: Various Factors Affect Patient Participation"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Dembner",
        "given": "Alice"
      }
    ],
    "citation-number": [
      "19."
    ],
    "title": [
      "Critics Say Drug Trials Often a Marketing Tool"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Stolberg",
        "given": "Sheryl Gay"
      },
      {
        "family": "Gerth",
        "given": "Jeff"
      }
    ],
    "container-title": [
      "New York Times"
    ],
    "date": [
      "2002-06-25",
      "2000-12-23"
    ],
    "location": [
      "Boston Globe"
    ],
    "title": [
      "Medicine Merchants: How Research Benefits Marketing"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Petersen",
        "given": "Melody"
      }
    ],
    "citation-number": [
      "20."
    ],
    "title": [
      "Madison Ave. Plays Growing Role in Drug Research"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Davidoff",
        "given": "Frank"
      },
      {
        "others": true
      },
      {
        "family": "Citizen",
        "given": "Public"
      }
    ],
    "container-title": [
      "New York Times",
      "New England Journal of Medicine, Sept",
      "Public Citizen Congress Watch"
    ],
    "date": [
      "2002-11-22",
      "2001",
      "2001-08-08"
    ],
    "pages": [
      "825–27 21"
    ],
    "title": [
      "Sponsorship, Authorship and Accountability",
      "Rx R&D Myths: The Case Against the Drug Industry’s R&D ‘Scare Card,’"
    ],
    "type": "article-journal",
    "volume": [
      "13"
    ]
  },
  {
    "author": [
      {
        "given": "Ernst"
      },
      {
        "family": "LLP",
        "given": "Young"
      }
    ],
    "citation-number": [
      "22."
    ],
    "note": [
      "Aug. 8, 2001, posted on the Pharmaceutical Research and Manufacturers Association Web site,"
    ],
    "title": [
      "Pharmaceutical Industry R&D Costs: Key Findings about the Public Citizen Report"
    ],
    "type": null,
    "url": [
      "http://www.phrma"
    ]
  },
  {
    "citation-number": [
      ".org/mediaroom/press/releases//2001-08-11.227.pdf"
    ],
    "note": [
      "accessed Oct. 15, 2003)."
    ],
    "type": null
  },
  {
    "citation-number": [
      "23."
    ],
    "date": [
      "2002-10-15"
    ],
    "title": [
      "Telephone interview with Baruch Lev"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Willman",
        "given": "David"
      }
    ],
    "citation-number": [
      "24."
    ],
    "container-title": [
      "Los Angeles Times"
    ],
    "date": [
      "1998-12-06"
    ],
    "title": [
      "‘Fast-Track’ Drug to Treat Diabetes Tied to 33 Deaths"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Sigelman",
        "given": "Daniel W."
      }
    ],
    "citation-number": [
      "25."
    ],
    "container-title": [
      "The American Prospect, Sept"
    ],
    "date": [
      "2002"
    ],
    "title": [
      "Dangerous Medicine"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "citation-number": [
      "26."
    ],
    "container-title": [
      "National Institute for Health Care Management Research and Education NOTES TO PAGES 242"
    ],
    "pages": [
      "– 254 279"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "given": "Foundation"
      },
      {
        "family": "Melody Peterson",
        "particle": "see also"
      }
    ],
    "container-title": [
      "New York Times"
    ],
    "date": [
      "2002-05",
      "2002-05-29"
    ],
    "title": [
      "Changing Patterns of Pharmaceutical Innovation",
      "New Medicines Seldom Contain Anything New, Study Finds"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "27."
    ],
    "date": [
      "2002-06-11"
    ],
    "genre": [
      "Fiction, a preliminary report,"
    ],
    "title": [
      "Pharmaceutical Research and Manufacturers Association, NIHCM’s Report on Pharmaceutical Innovation: Fact vs"
    ],
    "type": "report"
  },
  {
    "citation-number": [
      "28."
    ],
    "publisher": [
      "Ibid"
    ],
    "type": "book"
  },
  {
    "citation-number": [
      "29."
    ],
    "note": [
      "accessed Oct. 15, 2003)."
    ],
    "title": [
      "Industry statistics from the Biotechnology Industry Organization Web site"
    ],
    "type": null,
    "url": [
      "http://www.bio.org/news/stats.asp"
    ]
  },
  {
    "author": [
      {
        "family": "Pollack",
        "given": "Andrew"
      }
    ],
    "citation-number": [
      "30."
    ],
    "container-title": [
      "New York Times, Apr"
    ],
    "date": [
      "2002"
    ],
    "title": [
      "Despite Billions for Discoveries, Pipeline for Drugs Is Far from Full"
    ],
    "type": "article-journal",
    "volume": [
      "19"
    ]
  },
  {
    "author": [
      {
        "family": "Pollack",
        "given": "Andrew"
      }
    ],
    "citation-number": [
      "31."
    ],
    "container-title": [
      "New York Times, Apr"
    ],
    "date": [
      "2002"
    ],
    "title": [
      "Once Novel Drug Company No Longer Sets Pace"
    ],
    "type": "article-journal",
    "volume": [
      "18"
    ]
  },
  {
    "author": [
      {
        "family": "Harris",
        "given": "Gardiner"
      }
    ],
    "citation-number": [
      "32."
    ],
    "container-title": [
      "Wall Street Journal",
      "Wall Street Journal, Apr"
    ],
    "date": [
      "2000-07-06",
      "2002"
    ],
    "title": [
      "Drug Firms, Stymied in the Lab, Become Marketing Machines",
      "Gardiner Harris, “Why Drug Makers Are Failing in Quest for New Blockbusters"
    ],
    "type": "article-journal",
    "volume": [
      "18"
    ]
  },
  {
    "author": [
      {
        "family": "Harris",
        "given": "See"
      }
    ],
    "citation-number": [
      "33."
    ],
    "title": [
      "Why Drug Makers Are Failing"
    ],
    "type": null
  },
  {
    "citation-number": [
      "34."
    ],
    "date": [
      "2002-02-28"
    ],
    "location": [
      "San Diego"
    ],
    "publisher": [
      "University Technology Managers"
    ],
    "title": [
      "Speech to the Association of"
    ],
    "type": "book"
  },
  {
    "citation-number": [
      "35."
    ],
    "date": [
      "2001-10"
    ],
    "pages": [
      "66"
    ],
    "title": [
      "The Global Alliance for TB Drug Development, The Economics of TB Drug Development"
    ],
    "type": null
  },
  {
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Diuretic,” Journal of the American Medical Association"
    ],
    "date": [
      "2002-12-18",
      "2002-12-17"
    ],
    "genre": [
      "press conference,"
    ],
    "pages": [
      "2981–97"
    ],
    "publisher": [
      "National Heart, Lung and Blood Institute"
    ],
    "title": [
      "ALLHAT officers and coordinator for the ALLHAT Collaborative Research Group, “Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Frohlich",
        "given": "Edward D."
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "New England Journal of Medicine, Feb"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "639–41"
    ],
    "title": [
      "Treating Hypertension: What Are We to Believe?"
    ],
    "type": "article-journal",
    "volume": [
      "13"
    ]
  },
  {
    "author": [
      {
        "family": "Mayeux",
        "given": "Richard"
      },
      {
        "family": "Sano",
        "given": "Mary"
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "New England Journal of Medicine"
    ],
    "date": [
      "1999-11-25"
    ],
    "pages": [
      "1670–79"
    ],
    "title": [
      "Treatment of Alzheimer’s Disease"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "David Blumenthal",
        "given": "Interview",
        "particle": "with"
      }
    ],
    "citation-number": [
      "4."
    ],
    "date": [
      "2000-05-30"
    ],
    "title": [
      "Blumenthal, a professor at Harvard Medical School and director of the Massachusetts General Hospital Institute of Health Policy, has been tracking industry-university relations in medicine since the Carter administration"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Burton",
        "given": "Thomas M."
      },
      {
        "family": "Burton",
        "given": "Thomas M."
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Wall Street Journal, May",
      "Wall Street Journal"
    ],
    "date": [
      "2002",
      "2002-08-21"
    ],
    "title": [
      "Left on the Shelf: Why Cheap Drugs That Appear to Halt Fatal Sepsis Go Unused",
      "French Study Bolsters Steroids as Treatment for Deadly Sepsis"
    ],
    "type": "article-journal",
    "volume": [
      "17"
    ]
  },
  {
    "author": [
      {
        "family": "Altman",
        "given": "Stuart H."
      },
      {
        "family": "Parks-Thomas",
        "given": "Cindy"
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "New England Journal of Medicine, Mar"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "855–56"
    ],
    "title": [
      "Controlling Spending on Prescription Drugs"
    ],
    "type": "article-journal",
    "volume": [
      "14"
    ]
  },
  {
    "author": [
      {
        "family": "Angell",
        "given": "Marcia"
      }
    ],
    "citation-number": [
      "7."
    ],
    "title": [
      "The Pharmaceutical Industry"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Ltd",
        "given": "The S.N.P.Consortium"
      },
      {
        "family": "Rai",
        "given": "Arti K."
      },
      {
        "family": "S",
        "given": "Rebecca"
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "In a paper prepared for a conference at Duke University in Nov. 2002 (“The Public and the Private in Biopharmaceutical Research”), intellectual property law professors"
    ],
    "genre": [
      "Web site:"
    ],
    "title": [
      "Eisenberg argued that “the willingness of private firms in a patent-sensitive industry to spend money to enhance the public domain is powerful evidence that intellectual property rights in the research results threaten to create significant barriers to subsequent research and product development"
    ],
    "type": "paper-conference",
    "url": [
      "http://snp.cshl.org/about/."
    ]
  },
  {
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Academic Medicine"
    ],
    "date": [
      "2002-12-02"
    ],
    "editor": [
      {
        "family": "Korn",
        "given": "David"
      },
      {
        "family": "Heinig",
        "given": "Stephen J."
      }
    ],
    "title": [
      "This point is made in several articles contained",
      "Public versus Private Ownership of Scientific Discovery: Legal and Economic Analyses of the Implications of Human Gene Patents"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Hensley",
        "given": "Scott"
      }
    ],
    "citation-number": [
      "10."
    ],
    "container-title": [
      "Wall Street Journal"
    ],
    "date": [
      "Oct",
      "2002"
    ],
    "editor": [
      {
        "family": "G. D. Searle",
        "particle": "v."
      },
      {
        "family": "Co.",
        "given": "U.S.District"
      }
    ],
    "publisher": [
      "University of Rochester"
    ],
    "title": [
      "Pfizer Sues to Block Viagra Rivals"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "given": "Court"
      }
    ],
    "note": [
      "decided Mar. 5, 2003,"
    ],
    "title": [
      "Western District of New York"
    ],
    "type": null,
    "url": [
      "http://www.nywd"
    ]
  },
  {
    "citation-number": [
      ".uscourts.gov/decision/20030305_00cv6161_larimer.pdf"
    ],
    "note": [
      "accessed Mar. 5, 2003)."
    ],
    "type": null
  },
  {
    "citation-number": [
      "11."
    ],
    "title": [
      "See, for instance, the Web site of Campaign for Access to Essential Medicines on the Doctors Without Borders Web site"
    ],
    "type": null,
    "url": [
      "http://www.accessmed-msf"
    ]
  },
  {
    "author": [
      {
        "family": "Perlman",
        "given": "David"
      }
    ],
    "citation-number": [
      "12."
    ],
    "container-title": [
      "San Francisco Chronicle"
    ],
    "date": [
      "2002-08-19"
    ],
    "title": [
      "Drug Firm Seeks Cures over Cash"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "13."
    ],
    "container-title": [
      "Feb"
    ],
    "date": [
      "2003"
    ],
    "title": [
      "Interview with Victoria Hale"
    ],
    "type": "article-journal",
    "volume": [
      "26"
    ]
  },
  {
    "author": [
      {
        "given": "Perlman"
      }
    ],
    "citation-number": [
      "14."
    ],
    "title": [
      "Drug Firm Seeks Cures"
    ],
    "type": null
  },
  {
    "citation-number": [
      "15."
    ],
    "date": [
      "2002-06-21"
    ],
    "title": [
      "Interview with Carol Nacy"
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Drews"
      }
    ],
    "citation-number": [
      "16."
    ],
    "pages": [
      "234 17"
    ],
    "publisher": [
      "Nacy interview. Bibliography"
    ],
    "title": [
      "In Quest of Tomorrow’s Medicines"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Arno",
        "given": "Peter S."
      },
      {
        "family": "Feiden",
        "given": "Karyn L."
      }
    ],
    "date": [
      "1992"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "HarperCollins Publishers"
    ],
    "title": [
      "Against the Odds: The Story of AIDS Drug Development, Politics and Profits"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Asbury",
        "given": "Carolyn H."
      }
    ],
    "date": [
      "1985"
    ],
    "location": [
      "Lexington, Mass"
    ],
    "publisher": [
      "Lexington Books"
    ],
    "title": [
      "Orphan Drugs: Medical versus Market Value"
    ],
    "type": "book"
  },
  {
    "date": [
      "2002"
    ],
    "editor": [
      {
        "family": "Bailey",
        "given": "Ronald"
      }
    ],
    "location": [
      "Roseville, Calif"
    ],
    "publisher": [
      "Forum Publishing"
    ],
    "title": [
      "Global Warming and Other Eco-Myths: How the Environmental Movement Uses False Science to Scare Us to Death"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Bazell",
        "given": "Robert"
      }
    ],
    "date": [
      "1998"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "Random House"
    ],
    "title": [
      "Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Cohen",
        "given": "Jon"
      }
    ],
    "date": [
      "2001"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "W. W. Norton"
    ],
    "title": [
      "Shots in the Dark: The Wayward Search for an AIDS Vaccine"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Cook-Deegan",
        "given": "Robert"
      }
    ],
    "date": [
      "1994"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "W. W. Norton"
    ],
    "title": [
      "The Gene Wars"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Crewdson",
        "given": "John"
      }
    ],
    "date": [
      "2002"
    ],
    "location": [
      "Boston"
    ],
    "publisher": [
      "Little, Brown"
    ],
    "title": [
      "Science Fictions: A Scientific Mystery, a Massive Cover-up, and the dark Legacy of Robert Gallo"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Davies",
        "given": "Kevin"
      }
    ],
    "date": [
      "2002"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "The Free Press"
    ],
    "title": [
      "Cracking the Genome"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Drews",
        "given": "Jürgen"
      }
    ],
    "date": [
      "1999"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "Springer-Verlag"
    ],
    "title": [
      "In Quest of Tomorrow’s Medicines: An Eminent Scientist Talks about the Pharmaceutical Industry, Biotechnology, and the Future of Drug Research"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Epstein",
        "given": "Samuel S."
      }
    ],
    "date": [
      "1978"
    ],
    "location": [
      "San Francisco"
    ],
    "publisher": [
      "Sierra Club"
    ],
    "title": [
      "The Politics of Cancer"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Epstein",
        "given": "Samuel S."
      }
    ],
    "date": [
      "1998"
    ],
    "location": [
      "Fremont Center, N.Y"
    ],
    "publisher": [
      "East Ridge Press"
    ],
    "title": [
      "The Politics of Cancer Revisited"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Epstein",
        "given": "Steven"
      }
    ],
    "container-title": [
      "Bitter Pills: Inside the Hazardous World of Legal Drugs"
    ],
    "date": [
      "1996",
      "1998"
    ],
    "location": [
      "Berkeley",
      "New York"
    ],
    "publisher": [
      "University of California Press",
      "Bantam Books"
    ],
    "title": [
      "Impure Science: AIDS, Activism, and the Politics of Knowledge",
      "Fried, Stephen"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Gallo",
        "given": "Robert C."
      }
    ],
    "date": [
      "1991"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "Basic Books"
    ],
    "title": [
      "Virus Hunting: AIDS, Cancer, and the Human Retrovirus, a Story of Scientific Discovery"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Gambardella",
        "given": "Alfonso"
      }
    ],
    "date": [
      "1995"
    ],
    "location": [
      "Cambridge, England"
    ],
    "publisher": [
      "Cambridge University Press"
    ],
    "title": [
      "Science and Innovation: The U.S. Pharmaceutical Industry During the 1980s"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Goodman",
        "given": "Jordan"
      },
      {
        "family": "Walsh",
        "given": "Vivien"
      }
    ],
    "title": [
      "The Story of Taxol: Nature and Politics in"
    ],
    "type": null
  },
  {
    "date": [
      "2001"
    ],
    "location": [
      "Cambridge, England"
    ],
    "publisher": [
      "Cambridge University Press"
    ],
    "title": [
      "the Pursuit of an Anti-Cancer Drug"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Grabowski",
        "given": "Henry G."
      }
    ],
    "date": [
      "1994"
    ],
    "location": [
      "Washington, D.C"
    ],
    "publisher": [
      "AEI Press"
    ],
    "title": [
      "Health Reform and Pharmaceutical Innovation"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Greenberg",
        "given": "Daniel S.Science"
      }
    ],
    "date": [
      "2001"
    ],
    "location": [
      "Chicago"
    ],
    "publisher": [
      "University of Chicago Press"
    ],
    "title": [
      "Money, and Politics: Political Triumph and Ethical Erosion"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Harris",
        "given": "Richard"
      }
    ],
    "date": [
      "1964"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "The McMillan Company"
    ],
    "title": [
      "The Real Voice"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Johnson",
        "given": "Haynes"
      },
      {
        "family": "Broder",
        "given": "David S."
      }
    ],
    "date": [
      "1996"
    ],
    "location": [
      "Boston"
    ],
    "publisher": [
      "Little Brown and Co"
    ],
    "title": [
      "The System: The American Way of Politics at the Breaking Point"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Joyce",
        "given": "Christopher"
      }
    ],
    "date": [
      "1994"
    ],
    "location": [
      "Boston"
    ],
    "publisher": [
      "Little Brown and Co"
    ],
    "title": [
      "Earth Goods: Medicine-Hunting in the Rainforest"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Kenney",
        "given": "Martin"
      }
    ],
    "date": [
      "1984"
    ],
    "location": [
      "New Haven, Conn"
    ],
    "publisher": [
      "Yale University Press"
    ],
    "title": [
      "Biotechnology: The University-Industrial Complex"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Kluger",
        "given": "Richard"
      }
    ],
    "date": [
      "1997"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "Vintage Books"
    ],
    "title": [
      "Ashes to Ashes: America’s Hundred-Year Cigarette War, the Public Health, and the Unabashed Triumph of Philip Morris"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Kwitny",
        "given": "Jonathan"
      }
    ],
    "date": [
      "1992"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "Poseidon Press"
    ],
    "title": [
      "Acceptable Risks"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Fanu",
        "given": "Le"
      },
      {
        "given": "James"
      }
    ],
    "date": [
      "1999"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "Carroll and Graf Publishers"
    ],
    "title": [
      "The Rise and Fall of Modern Medicine"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Lerner",
        "given": "Barron H."
      }
    ],
    "date": [
      "2001"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "Oxford University Press"
    ],
    "title": [
      "The Breast Cancer Wars: Hope, Fear, and the Pursuit of a Cure in Twentieth-Century America"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Lewis",
        "given": "Sinclair Arrowsmith"
      }
    ],
    "date": [
      "1925",
      "1998"
    ],
    "genre": [
      "reprint,"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "Signet Classic"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Lewontin",
        "given": "Richard"
      }
    ],
    "date": [
      "2000"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "New York Review Books"
    ],
    "title": [
      "It Ain’t Necessarily So: The Dream of the Human Genome and Other Illusions"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Liebenau",
        "given": "Jonathan"
      }
    ],
    "date": [
      "1987"
    ],
    "location": [
      "Baltimore"
    ],
    "publisher": [
      "Johns Hopkins University Press"
    ],
    "title": [
      "Medical Science and Medical Industry: The Formation of the American Pharmaceutical Industry"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Mahoney",
        "given": "John Thomas"
      }
    ],
    "date": [
      "1959"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "Harper"
    ],
    "title": [
      "The Merchants of Life: An Account of the American Pharmaceutical Industry"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Marsa",
        "given": "Linda"
      }
    ],
    "date": [
      "1997"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "Scribner"
    ],
    "title": [
      "Prescription for Profits: How the Pharmaceutical Industry Bankrolled the Unholy Marriage between Science and Business"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "McKelvey",
        "given": "Maureen"
      }
    ],
    "date": [
      "1996"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "Oxford University Press"
    ],
    "title": [
      "Evolutionary Innovations: The Business of Biotechnology"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Mintz",
        "given": "Morton"
      },
      {
        "family": "Moore",
        "given": "Thomas J."
      }
    ],
    "date": [
      "1965",
      "1998"
    ],
    "location": [
      "Boston",
      "New York"
    ],
    "publisher": [
      "Beacon Press",
      "Simon and Schuster"
    ],
    "title": [
      "By Prescription Only",
      "Prescription for Disaster: The Hidden Dangers in Your Medicine Cabinet"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Mundy",
        "given": "Alicia"
      }
    ],
    "date": [
      "2001"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "St. Martin’s Press"
    ],
    "title": [
      "Dispensing with the Truth: The Victims, the Drug Companies, and the Dramatic Story Behind the Battle over Fen-phen"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Murdock",
        "given": "Rick"
      },
      {
        "family": "Fisher",
        "given": "David"
      }
    ],
    "date": [
      "2000"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "Crown Publishers"
    ],
    "title": [
      "Patient Number One: A True Story of How One CEO Took on Cancer and Big Business in the Fight of His Life"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Technology Assessment",
        "given": "Office",
        "particle": "of"
      }
    ],
    "date": [
      "1992"
    ],
    "publisher": [
      "Government Printing Office"
    ],
    "title": [
      "Federal and Private Roles in the Development and Provision of Alglucerase Therapy for Gaucher Disease, U.S"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Panem",
        "given": "Sandra"
      }
    ],
    "date": [
      "1994"
    ],
    "location": [
      "Washington, D.C"
    ],
    "publisher": [
      "Brookings Institution Press"
    ],
    "title": [
      "The Interferon Crusade"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Patterson",
        "given": "James T."
      }
    ],
    "date": [
      "1987"
    ],
    "location": [
      "Cambridge, Mass"
    ],
    "publisher": [
      "Harvard University Press"
    ],
    "title": [
      "The Dread Disease: Cancer and Modern American Culture"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Proctor",
        "given": "Robert N."
      }
    ],
    "date": [
      "1995",
      "1977"
    ],
    "location": [
      "New York",
      "Princeton, N.J"
    ],
    "publisher": [
      "Basic Books",
      "Princeton University Press"
    ],
    "title": [
      "Cancer Wars: How Politics Shapes What We Know and Don’t Know About Cancer",
      "Rettig, Richard A. Cancer Crusade"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Robbins-Roth",
        "given": "Cynthia"
      }
    ],
    "date": [
      "2000"
    ],
    "location": [
      "Cambridge, Mass"
    ],
    "publisher": [
      "Perseus Publishing"
    ],
    "title": [
      "From Alchemy to IPO: The Business of Biotechnology"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Rosenberg",
        "given": "Steven A."
      },
      {
        "family": "Barry",
        "given": "John M."
      }
    ],
    "date": [
      "1992"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "G. P. Putnam’s Sons"
    ],
    "title": [
      "The Transformed Cell: Unlocking the Mysteries of Cancer"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Ryan",
        "given": "Frank"
      }
    ],
    "date": [
      "1992"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "Little Brown and Co"
    ],
    "title": [
      "The Forgotten Plague: How the Battle Against Tuberculosis Was Won and Lost"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Schweitzer",
        "given": "Stuart O."
      }
    ],
    "date": [
      "1997"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "Oxford University Press"
    ],
    "title": [
      "Pharmaceutical Economics and Policy"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Shilts",
        "given": "Randy"
      }
    ],
    "date": [
      "1987"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "St. Martin’s Press"
    ],
    "title": [
      "And the Band Played On: Politics, People, and the AIDS Epidemic"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Shorter",
        "given": "Edward"
      }
    ],
    "date": [
      "1987"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "Doubleday"
    ],
    "title": [
      "The Health Century"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Silverman",
        "given": "Milton Morris"
      }
    ],
    "date": [
      "1948"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "Macmillan Co"
    ],
    "title": [
      "Magic in a Bottle"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Silverman",
        "given": "Milton"
      },
      {
        "family": "Lee",
        "given": "Philip R.Pills"
      }
    ],
    "date": [
      "1974"
    ],
    "location": [
      "Berkeley"
    ],
    "publisher": [
      "University of California Press"
    ],
    "title": [
      "Profits, and Politics"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Smith",
        "given": "Jane S."
      }
    ],
    "date": [
      "1990"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "William Morrow and Co"
    ],
    "title": [
      "Patenting the Sun: Polio and the Salk Vaccine"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Starr",
        "given": "Paul"
      }
    ],
    "date": [
      "1982"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "Basic Books"
    ],
    "title": [
      "The Social Transformation of American Medicine: The Rise of a Sovereign Profession and the Making of a Vast Industry"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Stokes",
        "given": "Donald E."
      }
    ],
    "date": [
      "1997"
    ],
    "location": [
      "Washington, D.C"
    ],
    "publisher": [
      "Brookings Institution Press"
    ],
    "title": [
      "Pasteur’s Quadrant: Basic Science and Technological Innovation"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Strickland",
        "given": "Stephen Parks"
      }
    ],
    "date": [
      "1972"
    ],
    "location": [
      "Cambridge, Mass"
    ],
    "publisher": [
      "Harvard University Press"
    ],
    "title": [
      "Politics, Science, and Dread Disease: A Short History of United States Medical Research Policy"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Strickland",
        "given": "Stephen Parks"
      }
    ],
    "date": [
      "1989"
    ],
    "location": [
      "Lanham, Md"
    ],
    "publisher": [
      "University Press of America"
    ],
    "title": [
      "The Story of the NIH Grants Programs"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Swann",
        "given": "John Patrick"
      }
    ],
    "date": [
      "1988"
    ],
    "location": [
      "Baltimore"
    ],
    "publisher": [
      "Johns Hopkins University Press"
    ],
    "title": [
      "Academic Scientists and the Pharmaceutical Industry: Cooperative Research in Twentieth-Century America"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Waldholz",
        "given": "Michael"
      }
    ],
    "date": [
      "1999"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "Touchstone Books"
    ],
    "title": [
      "Curing Cancer"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Weatherall",
        "given": "M."
      }
    ],
    "date": [
      "1990"
    ],
    "location": [
      "Oxford, England"
    ],
    "publisher": [
      "Oxford University Press"
    ],
    "title": [
      "In Search of a Cure"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Weinberg",
        "given": "Robert A."
      }
    ],
    "date": [
      "1999"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "Basic Books"
    ],
    "title": [
      "One Renegade Cell: How Cancer Begins"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Weinberg",
        "given": "Robert A."
      }
    ],
    "date": [
      "1998"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "W. H. Freeman and Co"
    ],
    "title": [
      "Racing to the Beginning of the Road: The Search for the Origin of Cancer"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Werth",
        "given": "Barry"
      }
    ],
    "date": [
      "1994"
    ],
    "location": [
      "New York"
    ],
    "publisher": [
      "Simon and Schuster"
    ],
    "title": [
      "The Billion-Dollar Molecule: One Company’s Quest for the Perfect Drug"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Young",
        "given": "James Harvey"
      }
    ],
    "date": [
      "1992"
    ],
    "location": [
      "Princeton"
    ],
    "publisher": [
      "Princeton University Press"
    ],
    "title": [
      "The Medical Messiahs: A Social History of Health Quackery in Twentieth-Century America"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Boyer",
        "given": "Applied Molecular Genetics See Amgen"
      },
      {
        "given": "Herbert"
      }
    ],
    "container-title": [
      "on Ceredase"
    ],
    "date": [
      "59"
    ],
    "location": [
      "Brady, Roscoe"
    ],
    "note": [
      "See also under cancer research Genzyme and, 49–50; life history Aranesp, 3, 33 and background, 42–43; and lyso-Argonne National Laboratory, 72–73 somal storage disorders, 49–50;"
    ],
    "pages": [
      "100"
    ],
    "title": [
      "21, 128 applied research, 15; funding for, 98"
    ],
    "type": "article-journal",
    "volume": [
      "48"
    ]
  },
  {
    "citation-number": [
      "259"
    ],
    "container-title": [
      "William J"
    ],
    "note": [
      "description, 92; and funding, drotrecogin alfa (Xigris),",
      "Amgen and, drug prices, 256–60; compared with their 25, 26; anemia and, 28; discovery of, benefits, 253; new battle over pricing, 13–14; Genetics Institute and, 25–27; 232–35; price controls, 7, 254; reasons Goldwasser and, 25–27, 250; kidney for high(er), 3, 234–35 dialysis patients and, 2, 19; Lin and, drug spending: annual national, 5; 25–28; price, 14; production, 17, 19,"
    ],
    "pages": [
      "69 92–93",
      "252 96–97, 118–20",
      "24"
    ],
    "title": [
      "118–21, 162; background and career, Dreyer",
      "HIV protease and, 96–drug applications: fees for new, 240; nor- 97, 118–19; Kempf and, 119–20; meetmal vs. priority status, 240–41 ing with NIH, 120; at NCI, 121; X-ray drug laws, 28 crystallography and, 93–94, 96, 121 drug prescriptions: inappropriate, 233; erythropoietin (Epo"
    ],
    "type": "article-journal",
    "volume": [
      "68",
      "80",
      "14, 24, 29, 38; number of, 233 Abbott and, 19, 23"
    ]
  },
  {
    "container-title": [
      "G",
      "discovery"
    ],
    "issue": [
      ""
    ],
    "note": [
      "effective-(SEC), 55–56, 159 ness, 186–87; FDA approval, 188; Seldane (terfenadine), 221, 223 price,",
      "research on, Selden, Richard, 53–55 186–87; supply and production, 187–"
    ],
    "pages": [
      "187–91",
      "185–86",
      "189–90"
    ],
    "title": [
      "science, basic/pure: research in, 98–101, Tartikoff, Brandon, 195 250 (see also under cancer research) tatIII and tat inhibitors, 110–11 Scolnick, Edward M., 106–8, 118, 132, tax deductions for research and develop-152, 182, 225 ment, 239–40 Searle",
      "adverse effects, 186, Securities and Exchange Commission 189"
    ],
    "type": "article-journal",
    "volume": [
      "D",
      "174",
      "124, 127"
    ]
  }
]
